UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-K


þ  ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31 2017, 2022

 

¨  

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


For the transition period from ______________________ to __________________________


Commission file number 000-20333


Nocopi Technologies, Inc.

(Exact name of registrant as specified in its charter)


Maryland

87-0406496

State or other jurisdiction of incorporation or organization

(I.R.S. Employer Identification No.)

480 Shoemaker Road, Suite 104, King of Prussia, PA

19406

(Address of principal executive offices)

(Zip Code)


(Registrant’s telephone number, including area code):(610) (610) 834-9600


Securities registered pursuant to Section 12(b) of the Act: None


Title of each class registered

Trading Symbol(s)

Name of each exchange on which registered


Securities registered pursuant to section 12(g) of the Act:


Common Stock, Par Value $0.01

(Title of class)


Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. ¨ Yes þNo


Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. ¨ Yes þNo


Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. þYes¨ No


Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). þYes¨ No


Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ¨


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer

¨ 

Accelerated filer

¨

Non-accelerated filer

¨ 

Smaller reporting company

þ

Emerging Growth Company

¨


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨


Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. 

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to §240.10D-1(b). 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act of 1934) ¨ Yes þNo


The aggregate market value of the voting and non-voting common equity held by non-affiliates of the registrant was approximately $2,637,000$9,574,000 as of June 30, 2017.2022.


As of March 27, 2018,13, 2023, there were 58,616,7169,251,178 shares outstanding of the registrant’s common stock, $0.01 par value.

 

Documents Incorporated By Reference







 


Portions of the registrant’s definitive proxy statement to be filed in conjunction with the registrant’s 2023 annual meeting of stockholders are incorporated by reference in Part III of this Annual Report on Form 10-K. The proxy statement will be filed by the registrant with the Securities and Exchange Commission not later than 120 days after the end of the registrant’s fiscal year ended December 31, 2022.

Table of Contents


Page

PART I

Item 1.

Business

1

Item 1A.

Risk Factors

5

Item 1B.

Unsolved Staff Comments

6

13

Item 2.

Properties

6

13

Item 3.

Legal Proceedings

6

13

Item 4.

Mine Safety Disclosures

6

13

PART II

Item 5.

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

7

14

Item 6.

Selected Financial Data

Reserved

8

14

Item 7.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

8

14

Item 7A.

Quantitative and Qualitative Disclosures About Market Risk

12

19

Item 8.

Financial Statements and Supplementary Data

12

19

Item 9.

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

12

19

Item 9A.

Controls and Procedures

12

19

Item 9B.

Other Information

13

20

Item 9C.

Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

20

PART III

PART III

Item 10.

Directors, Executive Officers and Corporate Governance

14

21

Item 11.

Executive Compensation

16

21

Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

18

21

Item 13.

Certain Relationships and Related Transactions, and Director Independence

19

21

Item 14.

Principal AccountingAccountant Fees and Services

19

21

PART IV

Item 15.

Exhibits,Exhibit and Financial Statement Schedules

20

22

Item 16.

Form 10-K Summary

20

22






i



 


Forward-Looking Statements


This report on Form 10-K contains forward-looking statements. Forward-looking statements involve risks and uncertainties, such as statements about our plans, objectives, expectations, assumptions or future events. In some cases, you can identify forward-looking statements by terminology such as “anticipate,” “estimate,” “plan,” “project,” “continuing,” “ongoing,” “expect,” “we believe,” “we intend,” “may,” “should,” “will,” “could” and similar expressions denoting uncertainty or an action that may, will or is expected to occur in the future. These statements involve estimates, assumptions, known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from any future results, performances or achievements expressed or implied by the forward-looking statements.

 

Examples of forward-looking statements include, but are not limited to:


·Expected operating results, such as revenue, expenses, and capital expenditures
·Current or future volatility in market conditions
·Our belief that we have sufficient liquidity to fund our business operations during the next twelve months
·Strategy for customer retention, product development, market position, and risk management

·

Expected operating results, such as revenue growth and earnings

·

Anticipated levels of capital expenditures for fiscal year 2018 and beyond

·

Current or future volatility in market conditions

·

Our belief that we have sufficient liquidity to fund our business operations during the next twelve months

·

Strategy for customer retention, growth, product development, market position, financial results and reserves

·

Strategy for risk management


Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following:following:


·The extent to which the COVID-19 pandemic may impact our future financial and operational performance will be dependent on many factors that we may not be able to predict because they continue to change and evolve depending on both national and local circumstances, among them being government restrictions affecting our employees, customers and suppliers, changes in our revenues due to lower customer demand as a result of the pandemic and a potential inability to obtain raw materials due to lower availability. We continue to monitor the impact of COVID-19 on our business but we cannot accurately predict the extent to which it will adversely affect our future results of operations, financial condition or cash flows.
·The extent to which we are successful in gaining new long-term relationships with customers or retaining significant existing customers and the level of service failures that could lead customers to use competitors' services.
·Strategic actions, including business acquisitions and our success in integrating acquired businesses.
·Our ability to improve our current credit rating with our vendors and the impact on our raw materials and other costs and competitive position of doing so.
·The impact of losing our intellectual property protections or the loss in value of our intellectual property.
·Changes in customer demand.
·The adequacy of our cash flow and earnings and other conditions which may affect our ability to timely service our debt obligations.
·The occurrence of hostilities, political instability or catastrophic events.
·Developments and changes in laws and regulations, including increased regulation of our industry through legislative action and revised rules and standards.
·Security breaches, cybersecurity attacks and other significant disruptions in our information technology systems.
·Such other factors as discussed throughout Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations in this report.

·

The extent to which we are successful in gaining new long-term relationships with customers or retaining significant existing customers and the level of service failures that could lead customers to use competitors' services.

·

Our ability to improve our current credit rating with our vendors and the impact on our raw materials and other costs and competitive position of doing so.

·

The impact of losing our intellectual property protections or the loss in value of our intellectual property.

·

Changes in customer demand.

·

The adequacy of our cash flow and earnings and other conditions which may affect our ability to timely service our debt obligations.

·

The occurrence of hostilities, political instability or catastrophic events.

·

Developments and changes in laws and regulations, including increased regulation of our industry through legislative action and revised rules and standards

·

Security breaches, cybersecurity attacks and other significant disruptions in our information technology systems; and

·

Such other factors as discussed throughout Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations in this report.


Any forward-looking statement made by us in this report is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.


ii 




ii




PART I


Item 1.

Business


Background


Nocopi Technologies, Inc. develops and markets specialty reactive inks for multiple applications in the large educational and toyacross various industries. Our specialty inks are used by our customers for a range of purposes from bringing entertainment products market. We also develop and market technologies forto life with a variety of color activations to providing document and productbrand authentication which we believe can reducefor security purposes aimed at reducing losses caused by fraudulent document reproduction or by product counterfeiting and/or diversion. Our primary markets are the large educational and toy products industry and the document and product authentication industry. We derive our revenues primarily from licensing our technologies on an exclusive or non-exclusive basis to licensees who incorporate our technologies into their product offering and from selling products incorporating our technologies to the licensees or to their licensed printers.


Unless the context otherwise requires, all references to the “Company,” “we,” “our” or “us” and other similar terms means Nocopi Technologies, Inc., a Maryland corporation. Our website address is www.nocopi.com. Also, this report on Form 10-K includes the trade names of other companies. Unless specifically stated otherwise, the use or display by us of such other parties' names and trade names in this report is not intended to and does not imply a relationship with, or endorsement or sponsorship of us by, any of these other parties.


Industry Overview and Market Trends

The key ingredients to an ink are pigments, dyes, resins, surfactants, dryers, oils, solvents, water, waxes, and various other additives. There are many different types of both printing processes and print applications, so the mixing or preparation of formulations for these quantities widely vary. Pigments and dyes are the key ingredient that comprise the ink’s color and are formulated from substances with certain characteristics that make them suitable for use on printed products.

The printing inks market is seeing a shift as companies transition from manufacturing petroleum-based printing inks to manufacturing environmentally friendly, more sustainable printing inks. “Green” printing inks are based on sustainable materials such as soy and other plant-based sources and do not contain the heavy metals or other dangerous and toxic substances that petroleum-based printing inks do; thus they do not cause excessive pollution in the landfill. Examples of more environmentally friendly printing inks include water-based and oil-based printing inks. The use of “green” printing inks also reduces emissions of volatile organic compounds (VOC) associated with the printing process.

In 2022, the global printing ink industry consumed 3 billion tons of printing ink according to Smithers industry report “The Future of Water-based vs Solvent Printing to 2027”. Sales of water-based inks in 2022 topped $5 billion and sales of solvent inks totaled $7.7 billion. The water-based printing inks market consists of sales of water-based printing inks and related services used for printing on fabric and paper. Water-based printing inks are referred to as aqueous inks and are dye and pigment inks and can be segmented by type into acrylic water-based inks, maleic water-based inks, and shellac water-based inks.

Our Company does not produce commodity base pigments. Rather, we source various pigments, dyes and other raw materials for ink, and then employ additional chemistry in formulating those materials into a highly engineered, specialty ink for a specific use. We are a specialty ink formulator within the ink industry that custom formulates, tests, and produces specialty inks that best meet our customer’s product needs and color demands. Our customers’ demands appear to be shifting with the trend towards utilizing more “green” printing inks. In 2022, approximately 38% of our ink sales were “green” printing inks, compared to 34% in 2021. As the “green” printing ink market continues to grow, we expect to continue to transition towards manufacturing environmentally friendly, more sustainable printing inks and away from manufacturing petroleum-based printing inks. We do not expect the “green” printing ink trend to adversely affect any aspects of our operations.

Products and Technology

We are a niche formulator of specialty inks and our specialty ink portfolio is backed by years of research and development efforts, trade secrets, and several patents we have been granted in the United States, Canada, South Africa, Saudi Arabia, Australia, New Zealand, Japan, France, the United Kingdom, Belgium, the Netherlands, Germany, Austria, Italy, Sweden, Switzerland, Luxembourg, and Liechtenstein. We currently have patent protection on substantially all our of security inks including our Rub & Reveal system and our Rub-It & Color technology.

Our goal is to provide our customers with specialized ink formulations with rapid design, test and production capabilities. We aim to serve our customers demand for unique product needs and security needs from our specialty inks through applying our industry knowledge, our technical expertise, our raw material procurement leverage, our product breadth, and our manufacturing operations capabilities to deliver ink formulations both domestically and internationally. We believe that our role in our customer’s value chain remains an essential component of their product offering as our customers continually rely upon supplier partners, such as our Company, that provide advanced solutions to improve their products' appeal, marketability, differentiation, performance, and overall competitive advantage.

We currently serve end markets that include children entertainment and toy products and anti-counterfeiting, anti-diversion segments that include industrial marking, security packaging for cosmetics and consumer products, and point of sales protection. We derive our revenues primarily from product sales of our inks as well as from licensing and royalty fees of our technologies on an exclusive or non-exclusive basis to licensees who incorporate our technologies into their product offering and from selling products incorporating our technologies to the licensees or to their licensed printers. We are currently seeking to expand into other markets.

Entertainment and Toy Technologies and Products


Since 2004,Across the Entertainment and Toy Products category, we have marketedmarket our Rub-it & Color technology to the entertainment and toy products market. This technologywhich consists of specialty inks that are produced in a variety of colors and can be revealed by rubbing with a fingernail or other firm object such as a plastic pen cap. Rub-it & Color ink technology can be used for coloring books, activity kits, play sheets, single use place mats, greeting cards, board games, promotional products, or any other paper-based application that’s needs some “fun” factor added. Two key features of our Rub-it & Color ink technology is that Safe and non-toxic, Rub-it and Color conforms to ASTM D4236 and F-963 and other toxicology tests.


Every child loves to color,Our customers in the Entertainment and every parent has a horror story about the cleanup.Toy Technologies and Products category capitalize on our mess free and non-toxic features of our ink products. Our patented, revolutionary, and award-winning Rub-it & Color takes out all the messy stuff related to children’s coloring except the fun. No more crayons ground into the carpet and car upholstery. No more spilled paint on the rug. No more messy markers ruining clothes and furniture. Rub-it & Color ink technology can be used for coloring books, activity kits, play sheets, single use place mats, greeting cards, board games, promotionalutilized across a variety of products or any other paper-based application that’s needsand applications needing some “fun” factor added. Safewhile still providing safe and non-toxic Rub-it and Color conformsconditions that conform to ASTM D4236 and F-963 and other toxicology tests.


We license our Rub-it & Color technology through various license agreements including:


A.

License agreement with a licensee who has a significant presence in the entertainmentthat can be for an exclusive and toy products market. A license agreement, in effect from January 2012 through December 2017, permitted this licensee to exclusively market: (1) anon-exclusive uses. These agreements cover both domestic and international geographies and can include specific linedistribution channels and specific lines of products incorporatingand applications. Historically our technologies through a specific distribution channellicense agreements have ranged anywhere from two to four years, but permitting us to licensecan also vary depending on the covered technologies to others for applicationscustomer, use, and sale through channels of distribution not available to this licensee under the termsgeography of the license, and (2) from January 2013 through December 2017, an additional technology on an exclusive basis in certain geographic areas of the world and on a non-exclusive basis in other geographic areas of the world. In early 2018, we entered into a new five-year license agreement with this licensee which permits the licensee to market products incorporating certain of our technologies, including the technologies permitted in the earlier license, on a non-exclusive basis throughout the world.


B.

License agreement containing guaranteed minimum royalties over the term of the license, which have been met, with Bendon, Inc. (Bendon), an international, well-known children’s coloring and activity book publishing company that permits Bendon to exclusively market products with other characteristics that incorporate our technologies through a distinctly different channel of distribution. This four-year license agreement was completed in June 2015, replacing a previous three-year license agreement. In early 2018, the license was amended to allow Bendon to: (1) market specific new technologies not covered in the license agreement, (2) expand certain rights relative to product content and design that were specifically excluded in the license agreement and (3) market merchandise permitted by the license through all channels of distribution, some of which were previously prohibited in the license agreement. This license expires in 2019.





C.

License agreement with a privately-held designer of creative educational products for children granting the licensee the exclusive right to utilize our Rub-it & Color ink technology in a newly-created vertical market in the United States. In addition to an annual license fee, we receive a royalty based on units of product produced. The license originated in 2011 and was renewed in June 2017 for a period of up to three years.


D.

License agreement with a privately-held children’s meal entertainment program provider that allows the licensee to use our Rub-it & Color ink technology in children’s menus, placemats, butcher paper and certain other products for restaurant use and for sale in certain children’s retail outlets. The license originated in November 2012 and was renewed in December 2014 for a period of six years, expiring in December 2020.


E.

License agreement with a privately-held international publisher of family products and publications based in Australia. The license originated in October 2015 and unless renewed, terminates in December 2018. The license agreement contains guaranteed minimum royalties and allows the licensee to market certain products that incorporate specific technologies of our Company on an exclusive basis in certain countries and on a non-exclusive basis in other countries with the exclusion of the United States, Canada and Mexico. The licensee introduced products incorporating our technologies in 2016.


Certain of our license agreements with licensees contain renewal options and/or guaranteed minimum royalties, while otherothers do not. We cannot assure you that any of our existing licenses will be renewed or will generate significant operating revenues for our Company in the future. In each of the years 20172022 and 2016,2021, we derived approximately 86%96% and 90%, respectively, of our total revenues from our licensees and their licensed printers in the entertainment and toy products market. We continue to pursue additional licensing opportunities for our Rub-it & Color ink technology in the large worldwide entertainment and toy products market through direct marketing efforts and attendance at trade shows. Wewe also seek to renew our existing license agreements with licensees.that are near expiration for extension terms.


Anti-Counterfeiting and Anti-Diversion Technologies and Products


Continuing developments in copying and printing technologies makes it easier than ever before to counterfeit a wide variety of documents. Counterfeit products are increasingly problematic for consumers, governments, and corporations. According to The Organization for Economic Cooperation and Development (OECD) data on counterfeiting and international trade, the total value of counterfeit and pirated goods was expected to increase to approximately $3 trillion in 2022. Product labels and packaging, retail receipts, event and transportation tickets and the like are all susceptible to counterfeiting, and product counterfeiting has long causedcausing economic losses to manufacturers of brand name products. With improvements in the copying and printing technologies making it easier to counterfeit labeling and packaging and increasing the losses to businesses from such counterfeiting appear to have increased substantially.activities.


Our COPIMARKCopimark and RUBRub & REVEALReveal technologies provide proprietary document authentication systems that are useful to businesses and brand owners desiring to authenticate a wide variety of printed materials and products. Our COPIMARKCopimark system enables businesses to print invisibly on certain areas of a document.document or packaging. When authentication of certain documentsdocument or packaging is required, the invisible printing can be activated or revealed by use of a special highlighter pen. Other variations of the COPIMARKour Copimark technology involve multiple color responses from a common pen, visible marks of one color that turn another color with the pen or visible and invisible marks that turn into a multicolored image. Our RUBRub & REVEALReveal system permits the invisible printing of an authenticating symbol or code that can be revealed by rubbing a fingernail over the printed area.


BothOur technologies provide users with the ability to authenticate documents and detect counterfeit documents. Applications include the authentication of documents having intrinsic value, such as merchandise receipts, checks, travelers' checks, gift certificates and event tickets, and the authentication of product labeling and packaging. When applied to product labels and packaging, our systems allow detection of counterfeit products, the labels and packaging of which would not contain the authenticating marks invisibly printed on the packaging or labels of the legitimate product.


Our marketing efforts for these technologies are focused on specific industries we believe may be affected by product counterfeiting. These technologies also combat product diversion (i.e. sale of legitimate products through unauthorized distribution channels or in unauthorized markets). Another of our related technologies, our invisible inkjet technology, permits manufacturers and distributors to track the movement of products from production to ultimate consumption when coupled with proprietary software. We anticipate that theThe “track and trace” capability provided by this technology will beis an attractive capability to brand owners and marketers and we hope that our ongoing marketing initiatives will resultowners. Our ink technology is also utilized in additional revenues in the future; although we cannot assure you that this will occur.


We currently participate in the retail receipt and document fraud marketmarkets through licensing arrangements with sevenfour printers and distributors in the United States and Canada who provide loss prevention products to retailers and other outlets. We market these technologies through the use of licensed printers and distributors and continue to use our available internal sales and technical resources to expand the number of licensees marketing our technologies in this market.distributors.





Contrast Technologies, formerly known as Euro-Nocopi, S.A., is a former affiliate of our Company that, since June 2003, has held a perpetual royalty-free license to exploitutilize certain of our anti-counterfeiting and anti-diversion technologies in Europe.


Product Revenue

 

The following table illustrates the approximate percentage of our Company’s total revenues accounted for by each type of its products for each of the two last fiscal years:


 

 

 

 

Year Ended December 31,

 

 Year Ended December 31, 

Product Type

 

 

 

 

2017

 

 

2016

 

 2022  2021 

 

 

 

 

 

 

 

 

 

     

Entertainment and Toy Technologies and Products

 

 

 

 

 

 

86

%

 

 

86

%

 96%  90% 

Anti-Counterfeiting and Anti-Diversion Technologies and Products

 

 

 

 

 

 

14

%

 

 

14

%

   4%  10%
        


Marketing


We have identified two major markets for our technologies and products, the entertainment and toy product market and the anti-counterfeiting/anti-diversion market. Our marketing approach focuses on the sufficient flexibility in our products and technologies and our ability to provide innovative, cost effective technologies for the entertainment and toy products market as well as solutions to a wide variety of counterfeiting, diversion and copier fraud problems. As a technology company, we generate revenues primarily by collecting license fees and royalties from market-specific businesses that incorporate our technologies into their products and, in certain cases, sales of our inks to these licensees and their designated manufacturers. We also license our technologies directly to end-users. Our current marketing efforts are focused on commercializing our developed technologies that can be utilizedacross current and new geographic and market areas. We sell products through both multiyear license agreements with our existing customers as well as direct sales to a range of end customers through the Company’s sales staff. We primarily use truck carriers and freight service providers to transport our products to customers from our manufacturing facility. Our marketing approach utilizes our dynamic production capabilities of our products and technologies.

Acquisition Strategy

Our growth strategy includes expanding our business through acquisitions of other companies with competing or complementary services, technologies or businesses in geographicorder to expand our product and service offerings to grow our free cash flow. We are currently actively engaged in the process to identify acquisition candidates and negotiate transactions. As of the date of this report on Form 10-K, we have no agreements to make any acquisition. We expect to fund our business expansion through the issuance of debt or market areas not contractually committed to an existing licensee on an exclusive basis. We presently market our technologies through our own employees, sales travel and attendance at trade shows.equity securities, the payment of cash, the exchange of services, or any combination thereof.



Major Customers


During 2017,2022, we made sales or obtained revenues equal to 10% or more of our Company’s 20172022 total revenues from two non-affiliated customers who individually accounted for approximately 43%66% and 26%19%, respectively, of 20172022 revenues of our Company. During 2016,2021, we made sales or obtained revenues equal to 10% or more of our Company’s 20162021 total revenues from threetwo non-affiliated customers who individually accounted for approximately 38%, 25%27% and 14%48%, respectively, of 20162021 revenues of our Company.


Additional information concerning our major customers is contained in Note 1210 to our Financial Statements, attached asAppendix A to this Annual Report on Form 10-K.


Manufacturing


Our Company operates a small manufacturing facility for the manufacture of its security inks that is located at our corporate headquarters at 480 Shoemaker Road, Suite 104, King of Prussia, Pennsylvania 19406,19406. At this location, we also have product development, sales, and we subcontractadministrative operations located adjacent to our production floor area. Our formulation and production methodologies aim to consistently achieve the manufacturehighest technical standards while simultaneously reaching fast lead times of certain of our applications (mainly certain printing inksproduction and coatings) to third party manufacturers. Our current mix of manufacturing processes are suitabledelivery for our Company, for both economic and technical reasons, and we have no plans to alter this mix in the near future. customers.

We have established a quality control program that currently entails laboratory analysis of developed technologies; and when warranted, our specially trained technicians travel to third party production facilities to install equipment, train client staff and monitor the manufacturing process. We also strive to improve our production efficiencies and data controls to target less material waste as well as attempt more sustainable sourcing of raw materials. 






Patents


Our Company has been granted various patents in the United States, Canada, South Africa, Saudi Arabia, Australia, New Zealand, Japan, France, the United Kingdom, Belgium, the Netherlands, Germany, Austria, Italy, Sweden, Switzerland, Luxembourg, and Liechtenstein. Patents may exist for 20 years from filing date and we actively monitor the marketplace to employ management processes designed to rigorously enforce our legal ownership of intellectual property. We currently have patent protection on substantially all of our security inks including the RUB & REVEAL system, and on our Rub-it & Color technology. Our latest patent protects our newly developed technology that may have applications in the entertainment and toy products market.


In the United States and some other countries, patent applications are automatically published at a specified time after filing. Since we are obligated pay annuities from time to time on our patents to keep them in force, we annually evaluate our patent portfolio to determine which patents we will continue to maintain. In Europe, annuities for European patents are paid by Contrast Technologies, formerly known as Euro-Nocopi, S.A., since Europe is where they hold a perpetual royalty-free license to exploit certain of our anti-counterfeiting and anti-diversion technologies.


Research and Development


We have been involved in theOur research and development activities are primarily focused on advancing our portfolio of ourink technologies. We aim to successfully develop new chemistry formulations, new market-changing technologies since our inception. Although several years ago our adverse financial condition forced us to limit funding forand new customer driven solutions. Our research and development weefforts support our commercial development activities while also attempting to improve our manufacturing operations.

We are presently actively conducting research and development activities in the following three areas, to the extent feasible:areas: (1) refining our present family of products,product portfolio, (2) developing specific customer applications, and (3) expanding our technology into new areas of implementation. During the years ended December 31, 20172022 and December 31, 2016,2021, we expended approximately $146,300$140,400 and $138,800,$181,500, respectively, on research and development. We cannot assure you that we will continue to have funds available to maintainfocus our research and development activities at current or increased levels.to develop and market additional new products and applications.


Competition


Nocopi Technologies competes in the fragmented specialty ink industry which is highly competitive. Competition is based on several key criteria which include quality, price, service, performance, product innovation, product recognition, speed, and delivery. Our Company has competitors in all segments of our business. The entertainment and toy products markets are highly competitive and includes numerous competitors. The loss prevention market also includes numerous competitors, includingrange from large, publicly tradedowned international companies with broad product offerings to local, privately held independent specialty producers offering a specific market niche or product. Overall, many participants tend to offer a varied and privately-held companiesbroad array of product lines designed to meet specific customer requirements.

The ink industry has become increasingly global as well as regional paper converters. In the areaparticipants have focused on establishing and maintaining leadership positions outside of documenttheir home markets. Many of these participant’s product lines face increasing competition due to industry consolidation, pricing pressures and product authentication and serialization, competitors offer competitive covert and overt surface marking technologies requiring decoding implements or analytical methods to reveal certain information that are marketed for the same anti-counterfeiting and anti-diversion purposes for which our Company markets its covertcompeting technologies. These include, among others, biological DNA codes, microtaggants, thermochromic, UV and infrared inks as well as encryption, 2D symbology and laser engraving. Nonetheless, we believe our patented and proprietary technologies provide a unique and cost-effective solution for our customers. To improve our competitive position, Nocopi Technologies is building and leveraging our corporate brand as a differentiator to the problem of counterfeitingcreate value and gray marketingbetter communicate our specialty production capabilities which we believe make it easier to introduce new product lines and applications to provide scale to our operations and ultimately enable us to successfully compete in the documentmarket.

Employees and product authentication markets it has traditionally sought to exploit.Human Capital


We are a small operating company and many of our existing and potential competitors have substantially greater research and product development capabilities and financial, marketing and human resources than we do.


Employees


We currently have threeeight full-time employees and two part-time employees. We believe that we have good relations with our employees.


We are committed to providing a healthy environment and safe workplace by operating in accordance with established health and safety protocols within our facility and maintaining a strong health and safety compliance program. We prioritize, manage, and carefully track safety performance at our facility and integrate sound safety practices in every aspect of our operations.

Regulation of our Business

We are subject to common business, tax and regulations pertaining to the operation of our business. We believe that we are in compliance with all applicable governmental regulations.

Financial Information about Foreign and Domestic Operations


We conduct our business operations solely within the United States; however, we have licensees and customers in Europe, South America, Asia and Australia. These licensees and customers accounted for approximately 54%28% of our gross revenues in 20172022 and approximately 56%58% of our gross revenues in 2016.2021. Additional information concerning our foreign and domestic operations is contained in Note 1210 to our Financial Statements, attached asAppendix A to this Annual Report on Form 10-K.






Item 1A.

Risk Factors


Our Company’s operating results, financial condition and stock price are subject to certain risks, some of which are beyond its control. These risks could cause theour Company’s actual operating and financial results to differ materially from those expressed in its forward-looking statements, including the risks described below and the risks identified in other documents which are filed and furnished with the United States Securities and Exchange Commission.


The novel strain of coronavirus (“COVID-19”) could have an adverse effect on our business operations.

Access

A novel strain of coronavirus, COVID-19, that was first identified in Wuhan, China in December 2019 has surfaced in many countries around the world including the United States. The World Health Organization has declared COVID-19 to Capital. Our Company anticipatesconstitute a global pandemic. Certain state and local governments reacted by placing significant restrictions on businesses including a closure in Pennsylvania of non-essential businesses that it may needwas announced on March 20, 2020. While many Pennsylvania businesses have been allowed to raise additional capital inreopen, often at limited capacity and with certain restrictions, as of the current date, there can be no assurances that future closures will be avoided. A requirement to fund its historical and new business operations. Additional financing may not be available to us, due to, among other things,close our Company for a considerable period of time could result in a negative impact on our Company’s financial condition and results of operations. Additionally, as our Company imports certain raw materials from China, if an extended disruption of the supply of these raw materials were to occur, our ability to produce products for sale to our customers could be negatively impacted. Further, restrictions on our customers and licensees in areas affected by the COVID 19 could adversely affect our results of operations and financial condition. We cannot predict the scope or magnitude of the negative effect that may result from the impact of the COVID-19 pandemic on the Company’s financial condition and results of operations. The COVID-19 pandemic has created significant worldwide uncertainty, volatility and economic disruption. The extent to which COVID-19 will negatively impact our results of operations, cash flow and financial position is dependent upon numerous factors, many of which are highly uncertain, rapidly changing and uncontrollable. These factors include, but are not having a sufficient income stream, profit level, asset base eligiblelimited to: (i) the duration and scope of the pandemic; (ii) governmental, business and individual actions that have been and continue to be collateralized,taken in response to the pandemic, including travel restrictions, quarantines, social distancing, work-from-home and shelter-in-place orders and shut-downs; (iii) the impact on U.S. and global economies and the timing and rate of economic recovery; (iv) potential adverse effects on the financial markets and access to capital; (v) potential goodwill or market for its securities. If we raise additional funds by issuing equity or convertible debt securities,other impairment charges; and (vi) the percentage ownershipability of our existing shareholders may be reduced,licensees and these securities may have rights superiorother customers to those ofsell products that utilize or incorporate our common stock. If adequate funds are not available to satisfy our long-term capital requirements, or if planned revenues are not generated, we may be required to substantially limit our operations or cease operations altogether. We cannot assure you that, if required, we will be successful in obtaining additional financing in sufficient amounts to fund our ongoing business operations.


technology.

Dependence on Major Customers

.We are dependent upon major customers.

We are dependent on our licensees to develop new products and markets that will generate increases in its licensing and product revenues. The inability of our licensees to maintain at least current levels of sales of products utilizing our technologies could adversely affect our operating results and cash flow. To the extent that our licensees are adversely affected by negative economic conditions such as those that may result from the present COVID 19 pandemic, our revenues may also be negatively impacted. We derive a significant percentage of our revenues through licensing relationships with two major customers. Revenues obtained directly from these customers and indirectly, through the customers’ third party licensed printers, equaled approximately 81%87% of theour Company’s revenues in 2017.2022. Receivables from these two licensees and their third party authorized printers were approximately 82%90% of theour Company’s net accounts receivable at December 31, 2017.2022. One of the license agreements expires in 20192028 and the other expires in 2022. Both license agreements containcontains guaranteed minimum royalties, which historically are met. The other license agreement expires in 2027. Both license agreements contain renewal options; but there can be no assurances that one or both of the licenses will continue in force at the same or more favorable terms beyond their current termination dates, nor can there be any assurances that the relationships with these two licensees will generate increased revenues for theour Company in the future.


Possible InabilityWe may be unable to Develop New Businessdevelop new business.

Our management believes that any significant improvement in theour Company’s cash flow must result from increases in revenues from traditional sources and from new revenue sources. Thesources, potentially including acquired businesses. Our Company’s ability to develop new revenues may depend on the extent of both its marketing activities, acquisition activities and its research and development activities, bothall of which are limited. We cannot assure you that the resources that theour Company can devote to marketing, finding suitable acquisitions and to research and development will be sufficient to increase its revenues to levels that will enable it to maintain positive operating cash flow in the future.


InabilityOur inability to Obtain Raw Materialssuccessfully acquire and Products for Resaleintegrate other businesses, assets, products or technologies could harm our operating results.. The Company’s adverse financial condition in years prior to 2016 has required it from

We are actively evaluating business acquisitions that we believe could complement or expand our existing product and service offerings. From time to time, we may enter into letters of intent with companies with which we are negotiating potential acquisitions or as to significantly defer paymentswhich we are conducting due diligence. Although we are currently not a party to (i) vendors who supplyany binding definitive agreement with respect to potential business acquisitions, we may enter into these types of arrangements in the future, which could materially decrease the amount of our available cash or require us to seek additional equity or debt financing. We have limited experience in successfully acquiring and integrating businesses, products and technologies. We may not be successful in negotiating the terms of any potential acquisition, conducting thorough due diligence, financing the acquisition or effectively integrating the acquired business, product or technology into our existing business and operations. Our due diligence may fail to identify all of the problems, liabilities or other shortcomings or challenges of an acquired business, product or technology, including issues related to intellectual property, product quality regulatory compliance practices, revenue recognition or other accounting practices, or employee or customer issues. We may encounter difficulties retaining key employees of the acquired company or integrating diverse business cultures.

Additionally, in connection with any business acquisitions we complete, we may not achieve the synergies or other benefits we expected to achieve, and we may incur write-downs, impairment charges or unforeseen liabilities that could negatively affect our operating results or financial position or could otherwise harm our business. If we finance acquisitions using existing cash, the reduction of our available cash could cause us to face liquidity issues or cause other unanticipated problems in the future. If we finance acquisitions by issuing equity securities, the ownership interest of our existing stockholders may be diluted, which could adversely affect the market price of our stock. Further, contemplating or completing an acquisition and integrating an acquired business could divert management and employee time and resources from other matters.

We may be unable to obtain raw materials and other components of its security inks, (ii) providers of professional and other services and (iii) certain employeesproducts for resale.

We use a large volume or raw materials. From time to whom salary and sales commissions are owed. As a result,time, the Company is required to pay cash in advance of shipment to certain of its suppliers. The inability to obtain materials on a timely basis and the possibility that certain vendors may permanently discontinue supplying theour Company with needed products and services may result in delayed shipments to customers and further impact theour Company’s ability to service its customers, thereby adversely affecting theour Company’s relationships with its customers and licensees. We cannot assure you that our Company will be able to maintain its vendor relationships in an acceptable manner.


Uneven PatternWe may experience uneven patterns of Quarterlyquarterly and Annual Operating Resultsannual operating results.

Our Company’s revenues, which are derived primarily from licensing and sales of products incorporating its technologies as well as royalties from these products, are difficult to forecast; such forecasting difficulty is due to, among other reasons, the long sales cycle of our Company’s technologies, the potential for customer delay or deferral of implementation of our Company’s technologies, the size and timing of inception of individual license agreements, the success of our Company’s licensees and strategic partners in exploiting the market for the licensed products, modifications of customer budgets, and uneven patterns of royalty revenue and product orders. As our revenue base is not substantial, delays in the finalization of license contracts, the implementation of the technology to initiate the revenue stream and the ordering decisions of customers can have a material adverse effect on our Company’s quarterly and annual revenue expectations. As our operating expenses are substantially fixed, income expectations will be subject to a similar adverse outcome. As licensees for the entertainment and toy products markets are added, the predictability of our Company’s revenue stream may be further impacted.




Other important factors that could cause our revenue and operating results to fluctuate from quarter to quarter include:



our ability to retain existing customers, attract new customers and satisfy our customers’ requirements;
general economic conditions;
changes in our pricing policies;
our ability to expand our business;
our ability to successfully integrate our acquired businesses;
new product and service introductions;
technical difficulties or interruptions in our services;
costs associated with future acquisitions of businesses; and
extraordinary expenses such as litigation or other dispute-related settlement payments.

Some of these factors are not within our control, and the occurrence of one or more of them may cause our operating results to vary widely. As such, we believe that quarter-to-quarter comparisons of our revenue and operating results may not be meaningful and should not be relied upon as an indication of future performance.

Volatility of Stock Price. The market price for our common stock has historically experienced significant fluctuations andOur intellectual property rights may continue to do so. With the exception of 2007, 2013, 2014, 2016 and 2017 from its inception, our Company has operated at a loss and has not produced revenue levels traditionally associated with publicly-traded companies. Our common stock is not listed on a national or regional securities exchange and, consequently, our Company receives limited publicity regarding its business achievements and prospects. Additionally, securities analysts and traders do not extensively follow our stock and it is thinly traded. The market price for our common stock may be affected by announcements of new relationships or modifications to existing relationships. The stock prices of many developing public companies, particularly those with small capitalizations, have experienced wide fluctuations not necessarily related to operating performance. Such fluctuations may adversely affect the market price of the Company’s common stock.


Intellectual Propertyfully protected.

Our Company relies on a combination of protections as may be available under applicable domestic, foreign or international patent, trademark and trade secret laws. We also rely on confidentiality, non-analysis and licensing agreements to establish and protect our rights in its proprietary technologies. While we attempt to protect these rights, our technologies may be compromised through reverse engineering, independent invention or other means. In addition, our ability to enforce our intellectual property rights through appropriate legal action has been and will continue to be limited by its tight liquidity. We cannot assure you that our Company will be able to protect the basis of its technologies from discovery by third parties or to preclude third parties from conducting activities that infringe on our Company’s rights. Our Company’s tight liquidity adversely impacts our ability to obtain patent protection on our intellectual property and to maintain protection on previously issued patents. We cannot assure you that we will be able to continue to prosecute new patents and maintain issued patents. As a result, our customer and licensee relationships could be adversely affected, and the value of our technologies and intellectual property (including their value upon liquidation) could be substantially diminished.


Economic ConditionsOur Company’s revenue is susceptible to changes in general economic conditions..

Our Company’s revenue is susceptible to changes in general economic conditions. Our sales, liquidity and overall results of operations may be negatively affected by decreasing consumer confidence, slowdowns in consumer spending or other downturns in the U.S. economy as a whole or in any geographic markets from which we derive revenue. In addition, these factors may result in decreased customer and licensee demand for our products and may negatively impact our ability to develop new customers and licensees. Due to uncertainties surrounding the worldwide economy, thatparticularly in light of the COVID-19 pandemic, the Russia-Ukraine war and the supply chain disruptions related to both, we are unable to predict the effect of such conditions on our customers and licensees. Consequently, we cannot predict the scope or magnitude of the negative effect resulting from ongoing global financial uncertainties or economic slowdowns.


PotentialWe are subject to regulatory compliance related to our operations.

We are subject to various U.S. governmental regulations related to occupational safety and health, labor and business practices. Failure to comply with current or future regulations could result in the imposition of substantial fines, suspension of production, alterations of our production processes, cessation of operations, or other actions, which could harm our business.

Certain financial instruments potentially subject our Company to concentrations of credit risk.

Certain financial instruments potentially subject our Company to concentrations of credit risk. These financial instruments consist primarily of cash, cash equivalents and accounts receivable. At December 31, 2022, our Company’s deposits and short-term investments with a financial institution were $4,838,000 in excess of the FDIC deposit insurance coverage of $250,000. There is a concentration of credit risk with respect to accounts receivable due to the number of major customers.

We may incur liability arising from the use of hazardous materials.

Our business and our facilities are subject to a number of federal, state and local laws and regulations relating to the generation, handling, treatment, storage and disposal of certain toxic or hazardous materials and waste products that we use or generate in our operations. Many of these environmental laws and regulations subject current or previous owners or occupiers of land to liability for the costs of investigation, removal or remediation of hazardous materials. In addition, these laws and regulations typically impose liability regardless of whether the owner or occupier knew of, or was responsible for, the presence of any hazardous materials and regardless of whether the actions that led to the presence were taken in compliance with the law. In our business, we use hazardous materials that are stored on site. We use various chemicals in our manufacturing process that may be toxic and covered by various environmental controls. An unaffiliated waste hauler transports the waste created by use of these materials off-site. Many environmental laws and regulations require generators of waste to take remedial actions at an off-site disposal location even if the disposal was conducted lawfully. The requirements of these laws and regulations are complex, change frequently and could become more stringent in the future. Failure to comply with current or future environmental laws and regulations could result in the imposition of substantial fines, suspension of production, alteration of our production processes, cessation of operations or other actions, which could severely harm our business.

We may be unable to protect our information systems from cybersecurity attacks or incidents, or if our information systems are otherwise disrupted.

We depend on information technology, including public websites and cloud-based services, for many activities important to our business. If we do not allocate and effectively manage the resources necessary to build and sustain our information technology infrastructure, if we fail to timely identify or appropriately respond to cybersecurity incidents, or if our information systems are damaged, destroyed or shut down (whether as a result of natural disasters, fires (either directly or through smoke damage), power outages, acts of terrorism or other catastrophic events, network outages, software, equipment or telecommunications failures, user errors, or from deliberate cyberattacks such as malicious or disruptive software, denial of service attacks, malicious social engineering, hackers or otherwise), our business could be disrupted and we could be subject to: transaction errors; processing inefficiencies; the loss of, or failure to attract, new customers; the loss of revenues from unauthorized use, acquisition or disclosure of or access to confidential information; the loss of or damage to intellectual property or trade secrets, including the loss or unauthorized disclosure of sensitive data, confidential information or other assets; damage to our reputation; litigation; regulatory enforcement actions; violation of data privacy, security or other laws and regulations; and remediation costs.

We conduct significantly all of our business and manufacturing activities at our King of Prussia, PA facility, and circumstances beyond our control may result in considerable business interruptions.

We conduct all of our operations activities at our King of Prussia, PA facility. Our operations are vulnerable to interruption by fire, earthquake, floods or other natural disaster, quarantines or other disruptions associated with infectious diseases, national catastrophe, terrorist activities, war, disruptions in our computing and communications infrastructure due to power loss, telecommunications failure, human error, physical or electronic security breaches and computer viruses, and other events beyond our control. We do not have a detailed disaster recovery plan.

Changes in accounting principles and guidance, or their interpretation, could result in unfavorable accounting charges or effects, including changes to our previously filed financial statements, which could cause our stock price to decline.

We prepare our financial statements in accordance with GAAP. These principles are subject to interpretation by the SEC and various bodies formed to interpret and create appropriate accounting principles and guidance. A change in these principles or guidance, or in their interpretations, may have a significant effect on our reported results and retroactively affect previously reported results.

We are a small public company and the requirements of being a public company are a strain on our systems and resources, are a diversion to management’s attention, and are costly.

As a public company, we are subject to the reporting requirements of the Securities Exchange Act of 1934 (Exchange Act) the Sarbanes-Oxley Act of 2002 (Sarbanes-Oxley Act), and the Dodd-Frank Wall Street Reform and Consumer Protection Act (Dodd-Frank Act). The requirements of these rules and regulations increase our legal, accounting and financial compliance costs, make some activities more difficult, time-consuming and costly and may also place strain on our personnel, systems and resources.

The Exchange Act requires, among other things, that we file annual, quarterly and current reports with respect to our business and operating results. The Sarbanes-Oxley Act requires, among other things, that we maintain effective disclosure controls and procedures and internal control over financial reporting. We are continuing the costly process of implementing and testing our systems to report our results as a public company, to continue to manage our growth and to implement internal controls. We are and will continue to be required to implement and maintain various other control and business systems related to our equity, finance, treasury, information technology, other recordkeeping systems and other operations. As a result of this implementation and maintenance, management's attention may be diverted from other business concerns, which could adversely affect our business.

In addition, changing laws, regulations and standards relating to corporate governance and public disclosure are creating uncertainty for public companies, increasing legal and financial compliance costs and making some activities more time consuming. These laws, regulations and standards are subject to varying interpretations, in many cases due to their lack of specificity, and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices. We intend to invest resources to comply with evolving laws, regulations and standards, and this investment may result in increased general and administrative expenses and a diversion of management's time and attention from revenue-generating activities to compliance activities. If our efforts to comply with new laws, regulations and standards differ from the activities intended by regulatory or governing bodies due to ambiguities related to their application and practice, regulatory authorities may initiate legal proceedings against us and our business may be adversely affected.

We expect these laws, rules and regulations to make it more difficult and more expensive for us to continue to obtain director and officer liability insurance, and we may be required to incur substantial costs to maintain appropriate levels of coverage. These factors could also make it more difficult for us to attract and retain qualified members of our board of directors, particularly to serve on our audit committee, and qualified executive officers.

As a result of being a public company, our business and financial condition is more visible, which we believe may result in threatened or actual litigation, including by competitors and other third parties. If such claims are successful, our business and operating results could be adversely affected, and even if the claims do not result in litigation or are resolved in our favor, these claims, and the time and resources necessary to resolve them, could divert the time and resources of our management and adversely affect our business and operating results.

As a smaller reporting company that is not an accelerated filer, we are subject to scaled disclosure requirements that may make it more challenging for investors to analyze our results of operations and financial prospects.

As a smaller reporting company that is not an accelerated filer we (i) are able to provide simplified executive compensation disclosures in our filings, (ii) are exempt from the provisions of Section 404(b) of the Sarbanes-Oxley Act requiring that independent registered public accounting firms provide an attestation report on the effectiveness of internal control over financial reporting and (iii) have certain other decreased disclosure obligations in our filings with the SEC, including being required to provide only two years of audited financial statements in annual reports. Consequently, it may be more challenging for investors to analyze our results of operations and financial prospects.

If we fail to maintain an effective system of disclosure controls and internal control over financial reporting, our ability to produce timely and accurate financial statements or comply with applicable regulations could be impaired.

As a public company, we are subject to the reporting requirements of the Securities Exchange Act of 1934 (Exchange Act) the Sarbanes-Oxley Act of 2002 (Sarbanes-Oxley Act), and the Dodd-Frank Wall Street Reform and Consumer Protection Act (Dodd-Frank Act). We expect that compliance with these rules and regulations will continue to increase our legal, accounting and financial compliance costs, make some activities more difficult, time consuming and costly, and place significant strain on our personnel, systems and resources.

The Sarbanes-Oxley Act requires, among other things, that we assess the effectiveness of our internal control over financial reporting annually and the effectiveness of our disclosure controls and procedures quarterly. In particular, Section 404 of the Sarbanes-Oxley Act, (Section 404), requires us to perform system and process evaluation and testing of our internal control over financial reporting to allow management to report on, the effectiveness of our internal control over financial reporting. Our compliance with applicable provisions of Section 404 requires that we incur substantial accounting expense and expend significant management time on compliance-related issues as we implement additional corporate governance practices and comply with reporting requirements. Moreover, if we are not able to comply with the requirements of Section 404 applicable to us in a timely manner, or if we or our independent registered public accounting firm identifies deficiencies in our internal control over financial reporting that are deemed to be material weaknesses, the market price of our stock could decline and we could be subject to sanctions or investigations by the SEC or other regulatory authorities, which would require additional financial and management resources. Furthermore, investor perceptions of our Company may suffer if deficiencies are found, and this could cause a decline in the market price of our stock. Irrespective of compliance with Section 404, any failure of our internal control over financial reporting could have a material adverse effect on our stated operating results and harm our reputation. If we are unable to implement these requirements effectively or efficiently, it could harm our operations, financial reporting, or financial results.

We may have undetected material weakness in internal controls.

Ourannual report does not include an attestation report of theour Company’s independent registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by theour Company’s registered public accounting firm pursuant to rules of the Securities and Exchange Commission that permit theour Company to provide only management’s attestation in this annual report. As a result,a material weakness in our internal controls may remain undetected for a longer period.

Our common stock is subject to volatility.

We cannot assure you that the market price for our common stock will remain at its current level, and a decrease in the market price could result in substantial losses for investors. The market price of our common stock may be significantly affected by one or more of the following factors:

·announcements or press releases relating to our industry or to our own business or prospects;
·regulatory, legislative, or other developments affecting us or our industry generally;
·sales by holders of restricted securities pursuant to effective registration statements or exemptions from registration; and
·market conditions specific to our Company, our industry and the stock market generally.

10 

Future sales of our shares could depress the market price of our common stock.

The market price of our common stock could decline as a result of sales of a large number of shares of our common stock in the market or the perception that these sales could occur. These sales, or the possibility that these sales may occur, also might make it more difficult for us to sell equity securities in the future at a time and at a price that we deem appropriate. Any disposition by any of our large shareholders of our common stock in the public market, or the perception that such dispositions could occur, could adversely affect prevailing market prices of our common stock.

We do not intend to pay any cash dividends on our securities, so you will not be able to receive a return on your investment unless you sell your shares.

We intend to retain any future earnings to finance the development and expansion of our business. We do not anticipate paying any cash dividends on our securities. Unless we pay dividends, our security holders will not be able to receive a return on their securities unless they sell them.

There is a limited market for our common stock, which may make it more difficult for you to sell your stock.

Our Company’s common stock is quoted on the OTC Market (OTC Pink) under the symbol "NNUP." The trading market for our common stock is limited, accordingly, there can be no assurance as to the liquidity of any markets that may develop for our common stock, your ability to sell our common stock, or the prices at which you may be able to sell our common stock.

Our common stock may be subject to the “penny stock” rules in the future. It may be more difficult to resell securities classified as “penny stock.”

The SEC has adopted regulations that generally define “penny stock” to be an equity security that has a market price of less than $5.00 per share, subject to specific exemptions.  While our common stock is not presently exempt from being considered a “penny stock” because our net tangible assets exceed $2 million and we have been in continuous operations for at least (3) years, if we are unable to continue to qualify for this exemption, or any other available exemption from the definition of “penny stock,” our common stock will become a “penny stock.” These rules impose additional sales practice requirements on broker-dealers that recommend the purchase or sale of penny stocks to persons other than those who qualify as “established customers” or “accredited investors.” For example, broker-dealers must determine the appropriateness for non-qualifying persons of investments in penny stocks. Broker-dealers must also provide, prior to a transaction in a penny stock not otherwise exempt from the rules, a standardized risk disclosure document that provides information about penny stocks and the risks in the penny stock market. The broker-dealer also must provide the customer with current bid and offer quotations for the penny stock, disclose the compensation of the broker-dealer and its salesperson in the transaction, furnish monthly account statements showing the market value of each penny stock held in the customer’s account, provide a special written determination that the penny stock is a suitable investment for the purchaser, and receive the purchaser’s written agreement to the transaction.

Legal remedies available to an investor in “penny stocks” may include the following:

·If a “penny stock” is sold to the investor in violation of the requirements listed above, or other federal or states securities laws, the investor may be able to cancel the purchase and receive a refund of the investment.

·If a “penny stock” is sold to the investor in a fraudulent manner, the investor may be able to sue the persons and firms that committed the fraud for damages.

These requirements may have the effect of reducing the level of trading activity, if any, in the secondary market for a security that becomes subject to the penny stock rules. The additional burdens imposed upon broker-dealers by such requirements may discourage broker-dealers from effecting transactions in our securities, which could severely limit the market price and liquidity of our securities. These requirements may restrict the ability of broker-dealers to sell our common stock or our warrants and may affect your ability to resell our common stock and our warrants.

Many brokerage firms will discourage or refrain from recommending investments in penny stocks. Most institutional investors will not invest in penny stocks. In addition, many individual investors will not invest in penny stocks due, among other reasons, to the increased financial risk generally associated with these investments.

11 

For these reasons, penny stocks may have a limited market and, consequently, limited liquidity. We can give no assurance at what time, if ever, our common stock or will not be classified as a “penny stock” in the future.

FINRA sales practice requirements may limit a stockholder’s ability to buy and sell our stock.

In addition to the “penny stock” rules described above, the Financial Industry Regulatory Authority (“FINRA”), has adopted rules that require that in recommending an investment to a customer, a broker-dealer must have reasonable grounds for believing that the investment is suitable for that customer. Prior to recommending speculative, low-priced securities to their non-institutional customers, broker-dealers must make reasonable efforts to obtain information about the customer’s financial status, tax status, investment objectives and other information. The FINRA requirements may make it more difficult for broker-dealers to recommend that their customers buy our common stock, which may have the effect of reducing the level of trading activity in our common stock. As a result, fewer broker-dealers may be willing to make a market in our common stock, reducing a stockholder’s ability to resell shares, as well as overall liquidity, of our common stock.

Provisions in the Company's charter and bylaws may delay or prevent an acquisition of the Company by a third party.

The Company's charter, bylaws and Maryland law contain provisions that could make it more difficult for a third party to acquire the Company without the consent of our Board. Additionally, these provisions could lower the price that future investors might be willing to pay for shares of our common stock. These anti-takeover provisions:

·authorize our board of directors to create and issue, without stockholder approval, preferred stock, thereby increasing the number of outstanding shares, which can deter or prevent a takeover attempt;
·prohibit cumulative voting in the election of directors, which would otherwise allow less than a majority of stockholders to elect director candidates;
·provide that any vacancy on the board of directors of the Company be filled only by the affirmative vote of a majority of the remaining directors then in office even if remaining directors do not constitute a quorum;
·provide that our board of directors be divided into three classes, with approximately one-third of the directors to be elected each year;
·provide that our board of directors is expressly authorized to adopt, amend or repeal our bylaws;
·provide that our directors will be elected by a plurality of the votes cast in the election of directors;
·provide that the Company’s stockholders may only remove any member of the Board by the affirmative vote of at least two-thirds of all the votes entitled to be cast by the stockholders generally in the election of directors and, such removal is required to be for cause; and
·provide that the number of directors of the Company shall be fixed only by vote of the board of directors;

Also, under Maryland law, business combinations, including mergers, consolidations, share exchanges, or, in circumstances specified in the statute, asset transfers or issuances or reclassifications of equity securities, between the Company and any interested stockholder, generally defined as any person who beneficially owns, directly or indirectly, 10% or more of the Company's common stock, or any affiliate of an interested stockholder are prohibited for a five-year period, beginning on the most recent date such person became an interested stockholder. After this period, a combination of this type must be approved by two super-majority stockholder votes, unless common stockholders receive a minimum price, as defined under Maryland law, for their shares in the form of cash or other consideration in the same form as previously paid by the interested stockholder for its shares. The statute permits various exemptions from its provisions, including business combinations that are exempted by our Board prior to the time that the interested stockholder becomes an interested stockholder.

12 

Our bylaws designate the Circuit Court for Baltimore City, Maryland as the sole and exclusive forum for certain actions, including derivative actions, which could limit a stockholder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with the Company and its directors, officers, other employees, or the Company's stockholders and may discourage lawsuits with respect to such claims.

Unless the Company consents in writing to the selection of an alternative forum, the Circuit Court for Baltimore City, Maryland (the “Maryland Circuit Court”) (or, if the Maryland Circuit Court does not have jurisdiction, the federal district court for the District of Maryland) (the “Exclusive Forum”) shall be the sole and exclusive forum for (a)(i) any action asserting an Internal Corporate Claim, as such term is defined in the MGCL (other than any action arising under federal securities laws), including, without limitation, (ii) any action asserting a claim of breach of the applicable standard of conduct or any duty owed by any director or officer or other employee of the Company to the Company or to the stockholders of the Company or (iii) any action asserting a claim against the Company or any director or officer or other employee of the Company arising pursuant to any provision of the MGCL, the Charter or these Bylaws, or (b) any other action asserting a claim against the Company or any director or officer or other employee of the Company that is governed by the internal affairs doctrine. Further, notwithstanding anything to the contrary in the foregoing, unless the Company consents in writing to the selection of an alternative forum, the federal district court for the District of Maryland (the “Securities Act Exclusive Forum”) shall be the sole and exclusive forum for resolution of any complaint asserting a cause of action arising under the Securities Act of 1933.

Although we believe these exclusive forum provisions benefit us by providing increased consistency in the application of Maryland law for the specified types of actions and proceedings, these provisions may limit a stockholder’s ability to bring a claim in a judicial forum that it finds favorable for disputes with the Company and its directors, officers, or other employees and may discourage lawsuits with respect to such claims.


Item 1B.

Unresolved Staff Comments


None.


Item 2.

Properties


Our corporate headquarters, research and ink production facilities are located at 480 Shoemaker Road, Suite 104, King of Prussia, Pennsylvania 19406. These premises consist of approximately 6,100 square feet of leased space. Our lease commenced in January 2014 and expires in April 2019.2024. Current monthly rent under this lease is $3,982;$4,595; this amount escalates an amount of approximately three percent each year. In addition to rent, we are also responsible for our pro-rata share of the operating costs of the building.


We incurred leasehold improvement expenditures of approximately $19,700$58,400 through March 27, 2018,13, 2023, and we believe that additional leasehold improvement expenditures will not be significant. We consider this space adequate for our current needs and additional space is available as needed.


Item 3.

Legal Proceedings


None.


Item 4.

Mine Safety Disclosures


Not applicable.




13 


PART II


Item 5.

Market For Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases Ofof Equity Securities


Market Information


Our common stock is traded on the OTC Pink tier of the over-the-counter (“OTC”) market under the symbol "NNUP". Investors can find Real-Time quotes and market information on theour Company on www.otcmarkets.com. The following table set forth below lists the range of high and low bids for our common stock for our two most recent fiscal years. The prices in the tableAny over-the-counter market quotations reflect inter-dealer prices, without retail markup, markdownmark-up, mark-down or commission and may not necessarily represent actual transactions.


 

 

High

 

Low

 

 

 

 

 

2016

1st Quarter

$.06  

 

$.006

 

2nd Quarter

$.043

 

$.01  

 

3rd Quarter

$.014

 

$.007

 

4th Quarter

$.023

 

$.009

 

 

 

 

 

2017

1st Quarter

$.033

 

$.017

 

2nd Quarter

$.05  

 

$.024

 

3rd Quarter

$.045

 

$.021

 

4th Quarter

$.05  

 

$.028


Shareholders

As of March 27, 2018, 13, 2023, we had approximately 58,616,716 have a total of 9,251,178 shares of common stock issued and outstanding, held by approximately 600 holders of record of our common stock. This shareholder figure does not include a substantially greater number of holders whose shares are held of record by banks, brokers and other financial institutions. We do not have anyapproximately 485 holders of our common stock, including The Depository Trust Company, which holds shares of preferredour common stock outstanding.on behalf of an indeterminate number of beneficial owners.


Dividends


NoOur Company does not pay any cash dividends have been declared or paidon its common stock. Our Business Loan Agreement with Santander Bank, N.A. restricts our ability to pay cash dividends on our common stock during our two most recent fiscal years. No restrictions limit our abilityand it will continue to pay dividends on our common stock. The payment of cash dividends in the future, if any, will be contingent upon our Company's revenues and earnings, capital requirements and general financial condition. The payment of any dividends is within the discretion of our board of directors. Our board of director's present intention is to retain all earnings, if any,do so for use in our business operations and, accordingly, the board of directors does not anticipate paying any cash dividends in the foreseeable future.


Securities Authorized for Issuance under Equity Compensation Plans


None.


Recent Sales of Unregistered Securities


During the period covered by this report, our Company sold the following securities without registering the securities under the Securities Act of 1933, as amended (“Securities Act”):


Date

Security

Security/Value

October 2017

September 2022

Common stockStock17,7002,500,000 shares of common stock issued at exercise prices ranging from $0.01 to $0.03the price of $1.40 per share issued pursuant to the exercisefor total proceeds of warrants

$3,500,000.


No underwriters were utilized, and no commissions or fees were paid with respect to any of the above transactions. These persons were the only offerees in connection with these transactions. We relied on Section 4(a)(2), 4(a)(5) and Rule 506 of and/or Regulation D of the Securities Act of 1933, as amended, since the transaction doestransactions did not involve any public offering.


Issuer Repurchases of Equity Securities


None.





Item 6.[Reserved]

Selected Financial Data


Not Applicable.


Item 7.

Management's Discussion and Analysis of Financial Condition and Results of Operations


The information in this report contains forward-looking statements. All statements other than statements of historical fact made in this report are forward looking. In particular, the statements herein regarding industry prospects and future results of operations or financial position are forward-looking statements. These forward-looking statements can be identified by the use of words such as “believes,” “estimates,” “could,” “possibly,” “probably,” anticipates,” “projects,” “expects,” “may,” “will,” or “should” or other variations or similar words. No assurances can be given that the future results anticipated by the forward-looking statements will be achieved. Forward-looking statements reflect management’s current expectations and are inherently uncertain. Our actual results may differ significantly from management’s expectations.


14 

The following discussion and analysis should be read in conjunction with our financial statements, included herewith. This discussion should not be construed to imply that the results discussed herein will necessarily continue into the future, or that any conclusion reached herein will necessarily be indicative of actual operating results in the future. Such discussion represents only the best present assessment of our management.


Background Overview


Nocopi Technologies, Inc. develops and markets specialty reactive inks for multiple applications in the large educational and toyacross various industries. Our specialty inks are used by our customers for a range of purposes from bringing entertainment products market. We also develop and market technologies forto life with a variety of color activations to providing document and productbrand authentication which we believe can reducefor security purposes aimed at reducing losses caused by fraudulent document reproduction or by product counterfeiting and/or diversion. Our primary markets are the large educational and toy products industry and the document and product authentication industry. We derive our revenues primarily from licensing our technologies on an exclusive or non-exclusive basis to licensees who incorporate our technologies into their product offering and from selling products incorporating our technologies to the licensees or to their licensed printers.


Unless the context otherwise requires, all references to the “Company,” “we,” “our” or “us” and other similar terms means Nocopi Technologies, Inc., a Maryland corporation.


Results of Operations


Our Company’s revenues are derived from (a) royalties paid by licensees of our technologies, (b) fees for the provision of technical services to licensees and (c) from the direct sale of (i) products incorporating our technologies, such as inks, security paper and pressure sensitive labels, and (ii) equipment used to support the application of our technologies, such as ink-jet printing systems. Royalties consist of guaranteed minimum royalties payable by our licensees in certain cases and additional royalties which typically vary with the licensee’s sales or production of products incorporating the licensed technology. Service fees and sales revenues vary directly with the number of units of service or product provided.


Our Company recognizes revenue on its lines of business as follows:


a.License fees for the use of our technology and royalties with guaranteed minimum amounts are recognized at a point in time when the term begins;
b.Product sales are recognized at the time of the transfer of goods to customers at an amount that our Company expects to be entitled to in exchange for these goods, which is at the time of shipment; and
c.Fees for technical services are recognized at the time of the transfer of services to customers at an amount that our Company expects to be entitled to in exchange for the services, which is when the service has been rendered.

a.

License fees and royalties are recognized when the license term begins. Upon inception of the license term, revenue is recognized in a manner consistent with the nature of the transaction and the earnings process, which generally is ratably over the license term;

b.

Product sales are recognized upon shipment of products, when the price is fixed or determinable and collectability is reasonably assured; and

c.

Fees for technical services are recognized when (i) the service has been rendered; (ii) an arrangement exists; (iii) the price is fixed or determinable based upon a per diem or hourly rate; and (iv) collectability is reasonably assured.


We believe that, as fixed cost reductions beyond those we have achieved in recent years may not be achievable, our operating results are substantially dependent on revenue levels. Because revenues derived from licenses and royalties carry a much higher gross profit margin than other revenues, operating results are also substantially affected by changes in revenue mix.






Both the absolute amount of our Company’s revenues and the mix among the various sources of revenue are subject to substantial fluctuation. We have a relatively small number of substantial customers rather than a large number of small customers. Accordingly, changes in the revenue received from a significant customer can have a substantial effect on our Company’s total revenue, revenue mix and overall financial performance. Such changes may result from a substantial customer’s product development delays, engineering changes, changes in product marketing strategies, production requirements and the like. We cannot predict whether inflation, interest rate increases, geopolitical instability and COVID-19, will materially affect our licensing fees or the demand for our products in 2023 and beyond. In addition, certain customers have, from time to time, sought to renegotiate certain provisions of their license agreements and, when our Company agrees to revise such terms, revenues from the customer may be affected.


15 

Comparison of the Years ended December 31, 20172022 and 20162021


Revenues for 20172022 were $1,566,900,$4,627,200, an increase of approximately 13%137%, or $183,400,$2,675,300, from $1,383,500$1,951,900 in 2016.2021. Revenues in 2022 included, in accordance with ASU 214-09, Revenue from Contracts with Customers (“Topic 606”), revenue of $2,810,600 from three licensees representing the present value of guaranteed royalty payments that will be payable over varying periods of two through five years that began in the second half of 2022 and terminate in the second quarter of 2028. The guaranteed royalty payments result from amendments to license agreements with two existing licensees and a license agreement with a new licensee. Since the performance obligation is to grant the licenses for the use of certain patented ink technology as it exists at the time that it is granted, the promise to grant the licenses are performance obligations satisfied at a point in time in accordance with Topic 606.


Licenses, royalties and fees increased in 20172022 by approximately 19%346%, or $105,600,$2,803,100, to $670,600$3,613,000 from $565,000$809,900 in 2016.2021. The increase in licenses, royalties and fees in 2022 compared to 2021 is due primarily to higher licensing revenuesroyalties from an existingour Company’s licensees in entertainment and toy products market including $2,810,600 representing the present value of guaranteed royalty payments that will be payable over varying periods of two to five years that began in the third quarter of 2022 as a result of amendments to license agreements with two licensees in the entertainment and toy products market that provide for five year extensions to the license agreements beginning in October 2022 described above. Additionally, our Company negotiated a license with a new licensee in the entertainment and toy products market who signed a new four-year licensecommencing in 2015 along with higher license feesOctober 2022 and royalties from certain licensees, including a new licenseeterminating in the anti-counterfeiting market.fourth quarter of 2024. We cannot assure you that the marketing and product development activities of our Company’s licensees or other businesses in the entertainment and toy products market will produce a significant increase in revenues for our Company beyond those achieved in 2022, nor can the timing of any potential revenue increases be predicted, particularly given the uncertain economic conditions being experienced worldwide as a result of the COVID-19 pandemic has negatively impacted all worldwide economies beginning in early 2020. The products marketed by the Company’s major licensees in the entertainment and toy products markets are produced in China. Trans-Pacific ocean shipping was negatively affected by container shortages and port delays both in the United States and China during 2022.


Product and other sales increaseddecreased by $77,800,$127,800, or approximately 10%11%, to $896,300$1,014,200 in 20172022 from $818,500$1,142,000 in 2016.2021. The higherlower level of ink sales in 20172022 compared to 20162021 is due primarily to higherlower ink requirements of the licensed third-partythird party authorized printers used by thetwo of our Company’s major licensees in the entertainment and toy products market. Sales of ink to the licensed printers of its licensees in the entertainment and toy products market were approximately $77,600 higher$137,700 lower in 20172022 compared to 2016.2021. Sales of security ink in 2022 to theour Company’s licensees in the retail receipt and document fraud market decreased by approximately $22,700 in 2017 compared to 2016.approximated 2021.


Our Company derived $1,340,500,$4,463,800, or approximately 86%96% of total revenues, from licensees and their licensed printers in the entertainment and toy products market in 20162022 compared to $1,193,000,$1,758,200, or approximately 86%90% of total revenues, in 2016.2021. The increase in revenues from our licensees and their authorized printers in the entertainment and toy products market in 2022 compared to 2021 is due primarily to the higher guaranteed royalties in accordance with Topic 606 resulting from a new license along with license extensions with two licensees in 2022. Our Company’s licensees in the entertainment and toy products market continue to develop new products for this market and improve their current offerings; however, their sales will be affected by marketplace reaction to the new and improved products, economic conditions that influence this market segment and the economy as a whole. Revenues that the Company derives from these licensees will be similarly affected. We cannot assure you that the marketing and product development activities of licensees in the entertainment and toy products market will produce increased revenues for the Company in future periods, nor can the timing of any potential revenue increases be predicted, particularly given the uncertain economic conditions currently beingthat continue to be experienced worldwide.worldwide as a result of COVID-19 and its variants including the now dominant XBB1.5 variant.


GrossOur Company’s gross profit increased to $1,123,800,$3,899,500, or approximately 72%84% of revenues, in 20172022 from $941,400,$1,213,800, or approximately 68% of62%, in 2021. The higher gross profit in 2022 compared to 2021 results primarily from higher gross revenues from licenses, royalties and fees offset in 2016. part by lower product and other sales in 2022 compared 2021.

Licenses, royalties and fees have historically carried a higher gross profit than product sales, which generally consist of supplies or other manufactured products that incorporate the Company’s technologies or equipment used to support the application of its technologies. These items (except for inks which are manufactured by theour Company) are generally purchased from third-party vendors and resold to the end-user or licensee and carry a lower gross profit than licenses, royalties and fees. The higher gross profit in 20172022 compared to 20162021 reflects higher gross revenues from licenses, royalties and fees andoffset in part by lower gross revenues from product and other sales in 20172022 compared to 2016.2021.


16 

As the variable component of cost of revenues related to licenses, royalties and fees is a low percentage of these revenues and the fixed component is not substantial, period to period changes in revenues from licenses, royalties and fees can significantly affect both gross profit from licenses, royalties and fees as well as overall gross profit. Due primarily to the higher revenues from licenses, royalties and fees in 20172022 compared to 2016,2021, the gross profit from licenses, royalties and fees increased to approximately 86%95% of revenues from licenses, royalties and fees in 20172022 from approximately 83%79% in 2016.2021.


GrossThe gross profit, expressed as a percentage of revenues, of product and other sales is dependent on both the overall sales volumes of product and other sales and on the mix of the specific goods produced and/or sold. Due to a favorable mix of products sold, theThe gross profit from product and other sales increaseddecreased to approximately 61%45% of revenues in 2017 from2022 compared to approximately 58%50% of revenues 2021. The decrease in 2016.gross profit in 2022 compared to 2021 is due primarily to lower ink shipments to the third party authorized printers used by two of our Company’s major licensees in the entertainment and toy products market.


Research and development expenses were $146,300$140,400 in 20172022 compared to $138,800$181,500 in 2016.2021. The increasedecrease in 20172022 compared to 20162021 resulted primarily from higherlower employee salary and benefitrelated expenses in 20172022 compared to 2016.2021.


Sales and marketing expenses were $253,600$494,500 in 20172022 compared to $236,000$287,700 in 2016.2021. The increase in 20172022 compared to 2016 resulted2021 is due primarily fromto higher commission expense in 2017 compared to 2016 resulting from a higheron the high level of revenues in 20172022 compared to 2016.2021.





General and administrative expenses increased to $317,600$1,219,200 in 20172022 from $294,800$719,400 in 2016.2021. The increase in 20172022 compared to 20162021 is due primarily to significantly higher legal, corporate relations and employee expenses in 2022 compared to 2021.

Income taxes in 2022 resulted primarily from higher employment costs, insurance expense and feesFederal income taxes on our Company’s taxable income offset in part by lower legal expenses in 2017 compared to 2016.


Other income (expenses) in 2017 and 2016 included interest on unsecured loans from two individuals and on convertible debentures held by nine investors. Also included in other income (expenses) is accretion of debt discounts in 2017 related to the extensionutilization of the maturity datesremaining Federal net operating loss carryforwards that existed prior to 2022 along with limitations placed on income tax net operating loss deductions by the Commonwealth of $33,300 of convertible debentures. Other income (expenses) increased to $25,100 in 2017 from $13,300 in 2016. This increase is due primarily to accretion of debt discounts in 2017 related to the extension of the maturity dates of $33,300 of convertible debentures in the first quarter of 2017.Pennsylvania.


The higherOur net income of $381,200$1,813,100 in 20172022 compared to $258,500net income of $49,400 in 20162021 resulted primarily from a higher gross profit on a higher level of revenues in 2017 compared to 2016licenses, royalties and fees offset in part by higher overhead expenses and higher accretion of debt discountsincome tax liabilities in 20172022 compared to 2016.2021.


Our management does not believe that inflation and changing prices have had a significant effect on our revenues and results of operations during the years ended December 31, 20172022 and December 31, 2016.2021.


Plan of Operation, Liquidity and Capital Resources


Our Company’s cash increased to $360,400$5,337,800 at December 31, 20172022 from $199,100$1,846,700 at December 31, 2016.2021. During 2017,2022, our Company received $3,500,000 upon the Company generated $177,500 fromsale of 2.5 million shares of its common stock pursuant to a private placement, used $8,100 in its operating activitiesreceived $400 upon the exercise of warrants, used $6,600 and $800 for capital equipment and repaid $10,000expenditures.

Our Company’s revenues increased approximately 137% to an individual lender.


During 2017, our revenues increased$4,627,200 in 2022 from $1,951,900 in 2021 primarily as a result of higher sales of ink to an authorized printer of one oflicensing revenue from the Company’s licensees in the entertainment and toy products market andmarket. Our Company’s gross profit increased approximately 221% to $3,899,500 in 2022 from $1,213,800 in 2021 primarily as a result of higher license fees from a licensee in the entertainment and toy products market offset in part by lower sales of ink to an existing authorized printer of certainour licensees in the entertainment and toy products market.


Our Company’s total overhead expenses increased in 20172022 compared 2016.to 2021, our Company’s net interest income increased in 2022 compared to 2021 and our Company’s income tax expense increased in 2022 compared to 2021. As a result of these factors, theour Company generated net income of $381,200$1,813,100 in 20172022 compared to $258,500$49,400 in 2016. The2021. Our Company had positivenegative operating cash flow of $177,500$8,100 in 2017.2022. At December 31, 2017, the2022, our Company had positive working capital of $201,100$6,421,800 and stockholders’ equity of $215,200.$8,818,400. For the full year of 2016, the2021, our Company had net income of $258,500$49,400 and had positive operating cash flow of $202,600.$512,700. At December 31, 2016, the2021, our Company had negative working capital of $194,600$3,197,500 and a $179,600 stockholders’ deficiency.equity of $3,505,300.


In 2017November 2018, our Company negotiated a $150,000 revolving line of credit (“Line of Credit”) with a bank to provide a source of working capital, if required. The Line of Credit is secured by all the assets of our Company and 2016,bears interest at the Company repaidbank’s prime rate for a period of one year and its prime rate plus 1.5% thereafter. The Line of Credit is subject to an annual review and quiet period. There have been no borrowings under the entire $23,500Line of short-term loans that had been outstanding at January 1, 2016 and presently has no short-term loans outstanding. The Company has $128,300 of convertible debentures outstanding that are due during the third quarter of 2018. These borrowings allowed the Company to remain in operation through late 2016 when the Company’s cash flow increased significantly.Credit since its inception.


In September 2017, our common stock private placement was extended to December 31, 2018 by the Company’s Board of Directors.


17 

We may need to obtain additional capital in the future to further support the working capital requirements associated with our existing revenue base and to fund potential operating losses that could occur if our licensees are unable to at least maintain current levels of sales of products utilizing the Company’s technologies.develop new revenue sources. We cannot assure you that we will be successful in obtaining sufficientsuch additional capital, or if we do so, that the additional capital will enable our Company to continue to operate profitably in the future and develop new revenue sources to have a material positive effect on the Company’s operations and cash flow. Without additional investment, we may be forced to cease operations at an undetermined time in the future if we are unable to sustain revenues at levels approximating revenues achieved in recent years.needed.


We continue to maintain a cost containment program including curtailment, where possible, of discretionary research and development and sales and marketing expenses.






Our plan of operation for the twelve months beginning with the date of this annual report consists of concentrating available human and financial resources to continue to capitalize on the specific business relationships our Company has developed in the entertainment and toy products market. This includes two licensees that have been marketing products incorporating the Company’s technologies since 2012. These two licensees maintain a significant presence in the entertainment and toy products market and are well known and highly regarded participants in this market. We anticipate that these two licensees will expand their current offerings that incorporate our technologies and will introduce and market new products that will incorporate our technologies available to them under their license agreements with our Company. We will continue to develop various applications for these licensees. We also plan to expand our licensee base in the entertainment and toy market. We currently have additional licensees marketing or developing products incorporating our technologies in certain geographic and niche markets of the overall entertainment and toy products market.


In late 2015, the Company added a licensee who began marketing products incorporating our available technologies in certain international markets in 2016. Our Company maintains its presence in the retail loss prevention market and expectsbelieves that revenue growth in this market can be achieved through increased security ink sales to its licensees in this market. We will continue to adjust our production and technical staff as necessary and, subject to available financial resources, invest in capital equipment needed to support potential growth in ink production requirements beyond our current capacity. Additionally, we will pursue opportunities to market our current technologies in specific security and non-security markets. There can be no assurances that these efforts will enable theour Company to generate additional revenues and positive cash flow.


Our Company has received, and continues tomay in the future seek, additional capital in the form of debt, equity or both, to support our working capital requirementsandrequirements and to provide funding for other business opportunities. WeBeyond the Line of Credit, we cannot assure you that if we require additional capital, that we will be successful in raisingobtaining such additional capital, or that such additional capital, if obtained, will enable our Company to generate additional revenues and positive cash flow.


As previously stated, we generate a significant portion of our total revenues from licensees in the entertainment and toy products market. These licensees generally sell their products through retail outlets. In the future, such sales may be adversely affected by changes in consumer spending that may occur as a result of an uncertain economic environment.environment in 2023 and beyond due to the ongoing COVID-19 pandemic and its effect on the global economy, geopolitical instability including the Russia-Ukraine war and the supply chain disruptions related to both as well as the record inflation, lower demand and significantly higher interest rates currently being experienced in the United States along with the probability of an economic recession both in the United States and globally. As a result, our revenues, results of operations and liquidity may be negatively impacted as they were in previous years.future periods.


Contractual Obligations


We conduct our operations in leased facilities under a non-cancelable operating lease expiring in 2019.2024. Future minimum lease payments under this operating lease at December 31, 20172022 are: $48,600$56,200 – 20182023 and $16,300$18,900 – 2019.2024. Total rental expense under operating leases was $45,100$53,300 in each of the years ended December 31, 20172022 and December 31, 2016.2021.


Recently Adopted Accounting Pronouncements


As of December 31, 2022, there were no recently adopted accounting standards that had a material effect on our Company’s financial statements.

Recently Issued Accounting Pronouncements Not Yet Adopted

In July 2015,June 2016, the FASB issued ASU No. 2015-11,2016-13, InventoryFinancial Instruments – Credit Losses (Topic 330)326),Simplifying the Measurement of InventoryCredit Losses on Financial Instruments. The amendments in this Update requireaffect loans, debt securities, trade receivables, and any other financial assets that have the contractual right to receive cash. The ASU requires an entity to measure inventory atrecognize expected credit losses rather than incurred losses for financial assets. For public entities, the lower of cost or net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Subsequent measurement is unchanged for inventory measured using LIFO or the retail inventory method. The amendments in this Update are effective for fiscal years beginning after December 15, 2016.2019, including interim periods within those fiscal years. ASU No. 2019-10 extends the effective dates for two years for smaller reporting companies and nonpublic companies.

18 

In August 2020, the FASB issued ASU No. 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40), Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. The Company adoptedamendments in this Update affect entities that issue convertible instruments and/or contracts in an entity’s own equity. For convertible instruments, the instruments primarily affected are those issued with beneficial conversion features or cash conversion features because the accounting models for those specific features are removed. However, all entities that issue convertible instruments are affected by the amendments to the disclosure requirements in this Update. For contracts in an entity’s own equity, the contracts primarily affected are freestanding instruments and embedded features that are accounted for as derivatives under the current guidance because of failure to meet the settlement conditions of the derivatives scope exception related to certain requirements of the settlement assessment. The Board simplified the settlement assessment by removing the requirements (1) to consider whether the contract would be settled in registered shares, (2) to consider whether collateral is required to be posted, and (3) to assess shareholder rights. Those amendments also affect the assessment of whether an embedded conversion feature in a convertible instrument qualifies for the derivatives scope exception. Additionally, the amendments in this Update on January 1, 2017 and there is no material impact of this guidance onaffect the financial statements.


In March 2016, the FASB issued ASU No. 2016-09,Compensation – Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting, which simplifies several aspects of the accountingdiluted EPS calculation for share-based payment award transactions, including: (1) income tax consequences; (2) classification of awards as either equity or liabilities, and (3) classification on the statement of cash flows. For public companies, the amendments in this ASU are effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. The Company adopted the amendments on January 1, 2017 and they had no impact on the financial statements since any excess tax benefits were fully offset by a valuation allowance and not recognized for financial statement purposes.






Recently Issued Accounting Pronouncements Not Yet Adopted


In May 2014 and April 2016, the FASB issued ASU No. 2014-09 and ASU No. 2016-10,Revenue from Contracts with Customers (Topic 606). The core principle of the guidance isinstruments that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This guidance will supersede current revenue recognition guidance which is effective for the Company on January 1, 2018. Under the new standard, the Company may be required to recognize revenue from license fees at the pointsettled in time when the license is granted as opposed to the recognition as earned over the license term which has been our historical practice. The Company has not determined the method to be used in applying the amendments in this standard. The Company, which presently has no significant new licensescash or license renewals pending, has not determined the method to be used in applying the amendments in this standard.


In May 2017, the FASB issued ASU No. 2017-09,Compensation – Stock Compensation (Topic 718), Scope of Modification Accounting. The amendments in this Update provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting.shares and for convertible instruments. The amendments in this Update are effective for allpublic business entities that meet the definition of a Securities and Exchange Commission (SEC) filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for annual periods, andfiscal years beginning after December 15, 2021, including interim periods within those annual periods,fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2017.2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The amendments in this UpdateBoard specified that an entity should be applied prospectively to an award modified on or afteradopt the adoption date. The Company does not expect the adoption on January 1, 2018guidance as of the amendments in this Updatebeginning of its annual fiscal year. The Board decided to haveallow entities to adopt the guidance through either a material impact on its financial statements.modified retrospective method of transition or a fully retrospective method of transition.


Off-Balance Sheet Arrangements


None.


Item 7a.

Item 7A. Quantitative and Qualitative Disclosures About Market Risk


Not Applicable.


Item 8.

Financial Statements and Supplementary Data


Our Financial Statements are attached asAppendix A (following Exhibits) and included as part of this Form 10-K Report. A list of our Financial Statements is provided in response to Item 15 of this Form 10-K Report.


Item 9.

Changes In And Disagreements With Accountants On Accounting and Financial Disclosure


None.


Item 9a.

Item 9A. Controls and Procedures


Evaluation of Disclosure Controls and Procedures


As of the end of the period covered by this report, our Company evaluated the effectiveness and design and operation of its disclosure controls and procedures. Our Company’s disclosure controls and procedures are the controls and other procedures that we designed to ensure that our Company records, processes, summarizes, and reports in a timely manner the information that it must disclose in reports that our Company files with or submits to the Securities and Exchange Commission. Our principal executive officer and principal financial officer reviewed and participated in this evaluation. Based on this evaluation, our Company made the determination that its disclosure controls and procedures were effective.


19 

Management'sManagement’s Annual Report on Internal Control Over Financial Reporting


Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). Under the supervision and with the participation of management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our internal controls over financial reporting based on the framework in Internal Control -Integrated– Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission ("COSO"(“COSO”). Based on this evaluation, management has concluded that our internal control over financial reporting was effective as of December 31, 2017.2022.






The Company'sOur Company’s internal control over financial reporting includes policies and procedures that (1) pertain to maintenance of records that, in reasonable detail, accurately and fairly reflect transactions and dispositions of the assets of theour Company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of theour Company are being made only in accordance with authorizations of management and directors of theour Company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company'sCompany’s assets that could have a material effect on the financial statements.


Our management, including our principal executive officer and principal financial officer, does not expect that our disclosure controls or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system'ssystem’s objectives will be met. Internal control over financial reporting is a process that involves human diligence and compliance and is subject to lapses in judgment and breakdowns resulting from human failures. In addition, the design of any system of controls is based in part on certain assumptions about the likelihood of future events, and controls may become inadequate if conditions change. There can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.


This annual report does not include an attestation report of theour Company’s independent registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by theour Company’s registered public accounting firm pursuant to rules of the Securities and Exchange Commission that permit theour Company to provide only management’s attestation in this annual report.


Changes in Company Internal Controls


No change in our Company’s internal control over financial reporting occurred during our fourth fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.


Item 9b.

Item 9B. Other Information


None.Not Applicable.




Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

Not Applicable.


20 


PART III


Item 10.

Directors, Executive Officers and Corporate Governance


Identity of directors, executive officers and significant employees


Name

Age

Position

Director Term*

Michael A. Feinstein, M.D.

71

Chair of the Board of Directors; Chief Executive Officer

1 year/Expires 2018

Terry W. Stovold

55

Chief Operating Officer

Rudolph A. Lutterschmidt

71

Vice President and Chief Financial Officer

Herman M. Gerwitz

64

Director

1 year/Expires 2018

Richard Levitt

61

Director

1 year/Expires 2018

Marc Rash

69

Director

1 year/Expires 2018

Philip B. White

79

Director

1 year/Expires 2018

———————

*

The term of office of each of the Directors is one (1) year, which continues until his successor has been elected and qualified.


Business experience of directors, executive officers, and significant employees


Michael A. Feinstein, M.D., 71, has served as our Chairman of the Board of Directors since December 1999 and our Chief Executive Officer since February 2000, has been a practicing physician in Philadelphia for more than thirty years, serving for more than twenty-five years as the President of a group medical practice which includes two physicians. He is a Fellow of the American College of Obstetrics and Gynecology and of the American Board of Obstetrics and Gynecology. He received his B.A. from LaSalle University and his M.D. from Jefferson Medical College. He has represented our Company in numerous licensing negotiations, governmental meetings and capital raises. The Board of Directors believes that Dr. Feinstein’s considerable personal experience as a business owner and investor in publicly traded businesses makes him well suited to serve as a member of our Board of Directors.


Terry W. Stovold, 55, has served as our Chief Operating Officer since July 2014, and has been employedinformation required by our Company for more than thirty years. Mr. Stovold previously served as our Company’s Director of Operations and Sales. Mr. Stovold received a Forestry Technician College degree from Algonquin College in Pembroke, Ontario, Canada and studied business at McGill University in Montreal, Canada. He holds numerous U.S. and foreign patents in the fields of printing technology and printing inks.


Rudolph A. Lutterschmidt, 71, has served as our Vice President and Chief Financial Officer since 1992, serving in this capacity on a part-time basis since January 2000. Mr. Lutterschmidt has been a consultant to several southeast Pennsylvania businesses. He is a graduate of Syracuse University.


Herman M. Gerwitz, CPA, 64, has served as our director since May 2005. He is presently the Treasurer of Keystone Property Group. Mr. Gerwitz has been with Keystone full time since 1998 and has been responsible for all the financial matters of a Real Estate Development Company that has grown to over 10 million square feet of commercial real estate and a $2 billion Real Estate Fund. Prior to joining Keystone, Mr. Gerwitz spent 20 years as a partner in a public accounting firm. He received a BBA from Temple University with master’s coursework at Widener University. He has been a member of both the Pennsylvania and American Institutes of Certified Public Accountants since 1983. The Board of Directors believes that Mr. Gerwitz’ many years as a Certified Public Accountant and his subsequent business management experience make him well suited to serve as a member of our Board of Directors and to serve on the Audit Committee of the Board of Directors.


Richard Levitt, 61, has served as our director since December 1999, and has been engaged in the computer and services segment of the computer industry since 1981. Mr. Levitt is currently a Senior Account Executive for Dell Computer in Pittsburgh, PA. He is in the Large Enterprise Group and is responsible for developing major accounts in Western Pennsylvania. Mr. Levitt has been with Dell since November 2005. In 2009, Mr. Levitt was awarded the “Circle of Excellence” award by Dell which is Dell’s highest corporate award given to less than 1% of its sales and support employees. In addition, he was awarded over the past three years the “Top Team Performer” and “Regional Top Performer” awards. In 1995, he participated in the founding of XiTech Corporation, a Pittsburgh, Pennsylvania-based provider of computing and computer networking hardware and network design and implementation services which in five years grew to over 100 employees and $50 million in annual sales. Since founding XiTech, Mr. Levitt served as one of its corporate principals, as a Network Consultant and as the Manager of its Network Sales Force. Mr. Levitt left XiTech in 2004. Before joining XiTech, Mr. Levitt served as a network sales executive for Digital Equipment Corporation from 1988 to 1994 and as a network consultant for TriLogic Corporation during 1994 and 1995. Mr. Levitt holds a B.S. in Marketing from Kent State University. The Board of Directors believes that Mr. Levitt’s sales and marketing experience in technology-based businesses, including start-ups and smaller businesses, makes him well suited to serve as a member of our Board of Directors.





Marc Rash, 69, has served as our director since September 2017, and is the Executive Vice President of Keystone Property Group, a Real Estate Development Company with over 10 million square feet of commercial real estate and a $2 billion Real Estate Fund. Mr. Rash, who joined Keystone in 1994, has extensive dealings with numerous lenders and investors as well as significant real estate experience, including the redevelopment of apartments, shopping centers and industrial/office space. Previously, Mr. Rash was an agent with the IRS specializing in auditing large corporations and high-net-worth individuals. Mr. Rash graduated from the University of North Carolina with a Bachelor of Science in Accounting and received his Juris Doctor degree from Delaware Law School. He is a member of the Pennsylvania Bar Association and the American Institute of Certified Public Accountants. The Board of Directors believes that Mr. Rash’s financial and legal background along with his banking and investor experience make him well suited to serve as a member of our Board of Directors.


Philip B. White, 79, has served as our director since August 2006. Mr. White is currently an international consultant in the private sector providing regulatory and industry standards advice to international companies regulated by the Food and Drug Administration, the Consumer Product Safety Commission, and the Environmental Protection Agency. He also served as a Technical Advisor and Regulatory Liaison to Nocopi from 2002 to 2005. Before establishing his own global consulting practice in 2000, Mr. White was, from 1994 to 2000, Director of Medical Device Consulting at the international firm of AAC Consulting Group (now Kendle), Rockville, MD. In 1994, Mr. White retired from a 33-year career with the U.S. Food and Drug Administration. His last FDA position was Director of the Office of Standards and Regulations in the Center for Devices and Radiological Health. Previous FDA positions included Regional Director of FDA’s enforcement activities in the Southwestern Region, Deputy FDA Assistant Commissioner for Program Coordination, and Supervisory Food and Drug Inspector. He has served on the Board of Directors of the American National Standards Institute, the Association for Advancement of Medical Instrumentation, and the Regulatory Affairs Professionals Society. He is a 1961 graduate of Wilkes University, Wilkes-Barre, PA with a B.A. Degree in Biology. He also did graduate studies in 1967 and 1968 specializing in the Federal Food Drug and Cosmetic Act at the New York University Graduate Law School in New York City. The Board of Directors believes that Mr. White’s considerable experience with consumer product safety and regulatory matters gained from his many years at the Food and Drug Administration makes him well suited to serve as a member of our Board of Directors.


The terms of all current directors expire at the 2018 annual meeting of stockholders of the Company.


Audit Committee Financial Expert


Our Company has established a standing audit committee in accordance with Section 3(a) (58) (A) of the Securities Exchange Act of 1934 that makes recommendations to the Company’s Board of Directors regarding the selection of an independent registered public accounting firm, reviews the results and scope of the Company’s audits and other accounting-related services and reviews and evaluates the Company’s internal control functions. The audit committee does not presently have a written charter. The audit committee is comprised of Michael A. Feinstein, M.D., its Chairman of the Board, and Herman M. Gerwitz, CPA. The Board of Directors has determined that Mr. Gerwitz is an “audit committee financial expert” as currently defined under the SEC rules implementing Section 407 of the Sarbanes Oxley Act of 2002 and that Mr. Gerwitz meets the criteria for independence as defined by the SEC.


Code of Ethics


Our Company has adopted a Code of Ethics that applies to its Principal Executive Officer, Principal Financial Officer, Principal Accounting Officer and persons performing similar functions. A copy of the Company’s Code of EthicsItem is incorporated by reference to Exhibit 14.1from the information contained within our Company’s definitive proxy statement for the 2023 Annual Meeting of this report on Form 10-K.Stockholders.






Section 16(a) Beneficial Ownership Reporting Compliance


Section 16(a) of the Securities Exchange Act of 1934 requires that our executive officers and directors, and persons who own more than ten percent of a registered class of our equity securities, file reports of ownership and changes in ownership with the SEC. Executive officers, directors and greater-than-ten percent stockholders are required by SEC regulations to furnish us with all Section 16(a) forms they file.To the best of our knowledge, based solely upon a review of Forms 3 and 4 and amendments thereto furnished to our Company during its most recent fiscal year and Forms 5 and amendments thereto furnished to our Company with respect to its most recent fiscal year, and any written representation referred to in paragraph (b)(1) of Item 405 of Regulation S-K,all of our executive officers, directors and greater-than-ten percent stockholders complied with all Section 16(a) filing requirements with the following exceptions:Mr. Marc Rash failed to timely file an Initial Form 3; Mr. Michael A. Feinstein failed to timely file a Form 4 nineteen times with respect to forty four transactions, and Mr. Herman M. Gerwitz failed to timely file one Form 4 with respect to two transactions.


Item 11.

Executive Compensation


The table below summarizes all compensation awarded to, earnedinformation required by or paid tothis Item is incorporated by reference from the information contained within our Named ExecutivesCompany’s definitive proxy statement for the fiscal years ended December 31, 2017 and 2016.


Summary Compensation Table


 

 

 

 

 

 

 

 

 

 

All other

 

 

 

 

 

 

 

 

Salary

 

 

Bonus

 

 

compensation

 

 

Total

 

Name and principal position

 

Year

 

($)

 

 

($)

 

 

($)

 

 

($)

 

                     (a)

 

(b)

 

(c)

 

 

(d)

 

 

(g)

 

 

(h)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Michael A. Feinstein, M.D.

 

2017

 

 

85,000

 

 

 

2,000

 

 

 

 

 

 

87,000

 

CEO, Pres. Chmn. of the Board (1)

 

2016

 

 

85,000

 

 

 

 

 

 

 

 

 

85,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Terry W. Stovold

 

2017

 

 

75,000

 

 

 

4,000

 

 

 

105,100

 

 

 

184,100

 

Chief Operating Officer (2)

 

2016

 

 

75,000

 

 

 

1,000

 

 

 

96,700

 

 

 

172,700

 

———————

1.

Dr. Feinstein entered into a written employment agreement effective June 1, 2008 under which he serves as President and Chief Executive Officer2023 Annual Meeting of the Company for an initial term of three years with successive one year renewal terms. In accordance with the terms of the employment agreement, the employment agreement renewed on December 1, 2017 for a period of one year effective June 1, 2018. The employment agreement provides for an annual base salary of $85,000 which may be increased annually at the discretion of the Board of Directors and an annual performance bonus determined by the Board of Directors. In certain situations, including a change in control, Dr. Feinstein may be eligible to receive his base salary for a period of up to twelve months following the termination of employment. The employment agreement prohibits him from competing with the Company during the term of this agreement and for two years after the termination of his employment with the Company. In each of the years ended December 31, 2017 and 2016, Dr. Feinstein deferred $85,000 of salary owed to him for each of those years. At December 31, 2017 and December 31, 2016, Dr. Feinstein was owed $200,000 and $301,200, respectively, of salary that was deferred by him.Stockholders.


2.

Mr. Stovold entered into a written employment agreement effective April 1, 2011 under which he served as the Company’s Director of Operations and Sales for an initial term of three years with successive one-year renewal terms. The employment agreement provides for a base salary set by the Company’s Board of Directors, which is currently set at $75,000 per year beginning on January 1, 2012, along with a commission of seven percent on sales generated by his efforts. The amount in column (g) reflects Mr. Stovold’s commissions on sales. In certain situations, including but not limited to a change in control, Mr. Stovold may be eligible to receive his base salary for a period of up to six months following the termination of employment. The employment agreement prohibits him from competing with the Company during the term of the agreement and for one year after the termination of his employment with the Company. At December 31, 2017, Mr. Stovold was owed approximately $44,000 of currently payable commissions related to sales realized in 2017 through his efforts. In July 2014, the Company’s Board of Directors appointed Mr. Stovold Chief Operating Officer of the Company. There were no changes to the employment agreement with Mr. Stovold resulting from this appointment.





Outstanding Equity Awards at Fiscal Year-End


None.


Director Compensation


The following table summarizes compensation earned by our Company’s directors for the year ended December 31, 2017. All directors have been and will be reimbursed for reasonable expenses incurred in connection with attendance at meetings of the Board of Directors or other activities undertaken by them on behalf of the Company.


 

 

Fees

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

earned

 

 

 

 

 

 

 

 

 

 

 

Nonqualified

 

 

 

 

 

 

 

 

 

or

 

 

 

 

 

 

 

 

Nonequity

 

 

deferred

 

 

 

 

 

 

 

 

 

paid in

 

 

Stock

 

 

Option

 

 

incentive plan

 

 

compensation

 

 

All other

 

 

 

 

 

 

cash

 

 

awards

 

 

awards

 

 

compensation

 

 

earnings

 

 

compensation

 

 

Total

 

Name

 

($)

 

 

($)

 

 

($)

 

 

($)

 

 

($)

 

 

($)

 

 

($)

 

Michael A. Feinstein, M.D. (1)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Herman M. Gerwitz (2)

 

 

2,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,000

 

Richard Levitt

 

 

2,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,000

 

Marc Rash

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Philip B. White

 

 

2,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2,000

 

———————

1.

Serves as an executive officer and a director, but receives no additional compensation for serving as a director.

2.

At December 31, 2017, Mr. Gerwitz held 26,665 warrants that became exercisable in July 2016.


Compensation Policies and Practices as They Relate to Our Risk Management


No risks arise from our Company’s compensation policies and practices for our employees that are reasonably likely to have a material adverse effect on our Company.






Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters


The following table sets forth, asinformation required by this Item is incorporated by reference from the information contained within our Company’s definitive proxy statement for the 2023 Annual Meeting of March 27, 2018, the stock ownership of (1) each person or group known to our Company to beneficially own 5% or more of our common stock and (2) each director and Named Executive (as set forth in Item 11. Executive Compensation) individually, and (3) all directors and executive officers of the Company as a group. To our knowledge, except as set forth in the footnotes to this table and subject to applicable community property laws, each person named in the table below has sole voting and investment power with respect to the shares set forth opposite such person’s name. Except as otherwise indicated, the address of each of the persons in the table below is c/o Nocopi Technologies, Inc., 480 Shoemaker Road, Suite 104, King of Prussia, Pennsylvania 19406.Stockholders.


Common Stock


Name of Beneficial Owner

 

Number

Of Shares

Beneficially

Owned

 

 

Percentage of

Class (1)(2)

 

5% Stockholders

 

 

 

 

 

 

Philip N. Hudson

P.O. Box 160892

San Antonio, TX 78280-3092 (3)

 

 

5,687,918

 

 

 

9.7

%

Westvaco Brand Security, Inc.

One High Ridge Park

Stamford, CT 06905 (4)

 

 

3,917,030

 

 

 

6.7

%

Ross. L Campbell

675 Lewis Lane

Ambler, PA 19002 (5)

 

 

3,264,457

 

 

 

5.6

%

 

 

 

 

 

 

 

 

 

Directors, Officers and Named Executive

 

 

 

 

 

 

 

 

Michael A. Feinstein, M.D. (6)

 

 

3,752,083

 

 

 

6.4

%

Herman M. Gerwitz (7)

 

 

630,214

 

 

 

1.1

%

Richard Levitt

 

 

299,000

 

 

 

*

 

Marc Rash (8)

 

 

208,333

 

 

 

*

 

Philip B. White (9)

 

 

311,245

 

 

 

*

 

Terry W. Stovold

 

 

12,000

 

 

 

*

 

All Executive Officers and Directors as a Group (7 individuals)

 

 

5,213,475

 

 

 

8.9

%

———————

* Less than 1.0%.


(1)

Where the Number of Shares Beneficially Owned (reported in the preceding column) includes shares which may be purchased upon the exercise of outstanding stock options and warrants which are or within sixty days will become exercisable (“presently exercisable options”) the percentage of class reported in this column has been calculated assuming the exercise of such presently exercisable options.

(2)

Based on 58,616,716 shares of common stock outstanding on March 27, 2018.

(3)

As reflected in a Schedule 13D dated August 11, 2008 filed on behalf of Philip N. Hudson and subsequent open market purchases as reported to the Company by Mr. Hudson.

(4)

As reflected in a Schedule 13D dated March 14, 2001 filed on behalf of Westvaco Brand Security, Inc.

(5)

As reflected in a Schedule 13D dated April 4, 2005 filed on behalf of Ross L. Campbell.

(6)

Includes 940,474 shares held by a pension plan of which Dr. Feinstein is the trustee and 1,443,868 shares held in an IRA.

(7)

Includes 50,000 shares held by a trust on behalf of a child of Mr. Gerwitz, 72,500 shares held by a child of Mr. Gerwitz, 6,000 shares held in an IRA and 26,665 presently exercisable warrants.

(8)

Held in an IRA.

(9)

Includes 17,000 shares held by Mr. White’s wife.


We are not aware of any arrangements that could result in a change of control.


Securities Authorized for Issuance under Equity Compensation Plans


Information regarding our compensation plans under which our equity securities are authorized for issuance can be found in Part II –Item 5 of this report.





Item 13.

Certain Relationships and Related Transactions, and Director Independence


Transactions with related persons


None.


Review, approval or ratification of transactions with related persons


Our Company does not have any formal written policies or procedures for related party transactions, however in practice, our Board of Directors reviews and approves all related party transactions and other matters pertaining to the integrity of management, including potential conflicts of interest, trading in our securities, or adherence to standards of business conduct.


Director Independence

 

Although we are currently traded onThe information required by this Item is incorporated by reference from the Over-the-Counter Markets,information contained within our BoardCompany’s definitive proxy statement for the 2023 Annual Meeting of Directors has reviewed each of the Directors’ relationships with the Company in conjunction with NASDAQ Listing Rule 5605(a)(2) that provides that an “independent director” is‘a person other than an Executive Officer or employee of the Company or any other individual having a relationship which, in the opinion of the Company's board of directors, would interfere with the exercise of independent judgment in carrying out the responsibilities of a director.’ Our Board of Directors has affirmatively determined that four of our directors, Herman M. Gerwitz, Richard Levitt, Marc Rash and Philip B. White are independent directors in that they are independent of management and free of any relationship that would interfere with their independent judgment as members of our Board of Directors. In making such determination, our Board of Directors considered the relationships that each such non-employee director has with our Company and all other facts and circumstances that our Board of Directors deemed relevant in determining their independence, including the beneficial ownership of our capital stock by each non-employee director. One member of our Board of Directors, Michael A. Feinstein, M.D., is not an independent director pursuant to the standards described above.Stockholders.


Our audit committee is comprised of Michael A. Feinstein, M.D. and Herman M. Gerwitz, CPA.Our Company does not have a separately designated nominating or compensation committee or committee performing similar functions; therefore, our full Board of Directors currently serves in these capacities


Item 14.

Principal AccountingAccountant Fees and Services


The aggregate fees billed for the years ended December 31, 2017 and December 31, 2016 for professional services rendered by Morison Cogen, LLP for the audit of the Company’s annual financial statements and review of financial statements included in the Company’s Form 10-Q or services that are normally provided by Morison Cogen, LLP in connection with statutory and regulatory filings or engagements were $42,000 for the year ended December 31, 2017 and $41,000 for the year ended December 31, 2016.


Audit-Related Fees


Fees billed for the years ended December 31, 2017 and December 31, 2016 for assurance and related services rendered by Morison Cogen, LLP that are reasonably related to the performance of the audit or review of the Company’s financial statements and are not reported under the category Audit Fees described above were $0 for the year ended December 31, 2017 and $0 for the year ended December 31, 2016.


Tax Fees


Fees billed for the years ended December 31, 2017 and December 31, 2016 for tax compliance, tax advice and tax planning services rendered by Morison Cogen, LLP were $3,000 for the year ended December 31, 2017 and $3,000 for the year ended December 31, 2016.


All Other Fees


Fees billed for the years ended December 31, 2017 and December 31, 2016 for products and services provided by Morison Cogen, LLP, other than the services reported in the Audit Fees, Audit-Related Fees, and Tax Fees categories above were $0 for the year ended December 31, 2017 and $0 for the year ended December 31, 2016.


Audit Committee Approval


The Company’s audit committee currently does not have any pre-approval policies or procedures concerning services performed by Morison Cogen, LLP. All the services performed by Morison Cogen, LLP that are described above were pre-approved by the Company’s audit committee.

 



The information required by this Item is incorporated by reference from the information contained within our Company’s definitive proxy statement for the 2023 Annual Meeting of Stockholders.


21 


PART IV


Item 15.

Exhibits,Exhibit and Financial Statement Schedules


(a)

The following Audited Financial Statements are filed as part of this Form 10-K Report:

Report of Independent Registered Public Accounting Firm

Balance Sheets

Statements of Operations

Comprehensive Income

Statement of Stockholders’ Equity (Deficiency)

Statements of Cash Flows

Notes to Financial Statements

(b)

The following exhibits are filed as part of this report.

See Exhibit Index.


Item 16.

Form 10-K Summary


None.





22 


SIGNATURES


Pursuant to the requirements of Section 13 of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


NOCOPI TECHNOLOGIES, INC.

Date: March 29, 2018

31, 2023

By:

/s/ Michael A. Feinstein, M.D.

Michael A. Feinstein, M.D.

Chairman of the Board, President and Chief Executive Officer (Principal Executive Officer)



Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.



Signature

Title

Date

/s/ Michael A. Feinstein, M.D.

Chairman of the Board, President and Chief Executive Officer (Principal Executive Officer)

March 29, 2018

31, 2023

Michael A. Feinstein, M.D.

/s/ Rudolph A. Lutterschmidt

Vice President, Chief Financial Officer and Chief Accounting Officer (Principal Financial and Accounting Officer)

March 29, 2018

31, 2023

Rudolph A. Lutterschmidt

/s/ Herman M. Gerwitz

Jacqueline J. Goldman

Director

March 29, 2018

31, 2023

Herman M. Gerwitz

Jacqueline J. Goldman

/s/ Richard Levitt

Michael S. Liebowitz

Director

March 29, 2018

31, 2023

Richard Levitt

Michael S. Liebowitz

/s/ Marc Rash

Director

March 29, 2018

31, 2023

Marc Rash

/s/ Philip B. White

Joseph Raymond

Director

March 29, 2018

31, 2023

Philip B. White

Joseph Raymond

/s/ Matthew C. WingerDirectorMarch 31, 2023
Matthew C. Winger















23 


INDEX TO FINANCIAL STATEMENTS


Report of Independent Registered Public Accounting Firm

F-2

Balance Sheets as of December 31, 20172022 and 2016

2021

F-3

Statements of OperationsComprehensive Income for the Years ended December 31, 20172022 and 2016

2021

F-4

Statement of Stockholders’ Equity (Deficiency) for the Years ended December 31, 20172022 and 2016

2021

F-5

Statements of Cash Flows for the Years ended December 31, 20172022 and 2016

2021

F-6

Notes to Financial Statements

F-7









F-1 


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM



To the Board of Directors and

Stockholders of Nocopi Technologies, Inc.


Opinion on the Financial Statements


We have audited the accompanying balance sheets of Nocopi Technologies, Inc. (the Company) as of December 31, 20172022 and 2016,2021, and the related statements of operations,comprehensive income, stockholders’ deficiency,equity, and cash flows for each of the two years in the two-year period ended December 31, 2017,2022, and the related notes (collectively referred to as the financial statements). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 20172022 and 2016,2021, and the results of its operations and its cash flows for each of the two years in the two-year period ended December 31, 2017,2022, in conformity with accounting principles generally accepted in the United States of America.


Basis for Opinion


These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.


We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.


Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.



Critical Audit Matters

Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there are no critical audit matters.

/s/ Morison Cogen LLP (PCAOB-536)


We have served as the Company’s auditor since 2001.


Blue Bell, Pennsylvania

March 29, 201831, 2023








F-2 


Nocopi Technologies, Inc.

Balance Sheets*


 

 

December 31

 

 December 31 

 

2017

 

2016

 

 2022  2021 

Assets

 

 

 

 

 

        

 

 

 

 

 

Current assets

 

 

 

 

 

        

Cash

 

$

360,400

 

$

199,100

 

Accounts receivable less $5,000 allowance for doubtful accounts

 

292,100

 

243,400

 

Cash and cash equivalents $5,337,800  $1,846,700 
Accounts receivable less $12,000 allowance for doubtful accounts  1,103,500   970,800 

Inventory

 

110,600

 

70,900

 

  486,400   422,700 

Prepaid and other

 

 

35,300

 

 

 

29,600

 

  103,300   160,000 

Total current assets

 

 

798,400

 

 

 

543,000

 

  7,031,000   3,400,200 

 

 

 

 

 

Fixed assets

 

 

 

 

 

        

Leasehold improvements

 

19,700

 

19,700

 

  58,400   58,400 

Furniture, fixtures and equipment

 

 

184,900

 

 

 

178,300

 

  164,400   164,100 

 

204,600

 

198,000

 

Fixed assets, gross  222,800   222,500 

Less: accumulated depreciation and amortization

 

 

190,500

 

 

 

183,000

 

  167,800   134,200 

 

 

14,100

 

 

 

15,000

 

Total fixed assets   55,000   88,300 
Other assets        
Long-term receivables  2,463,100   185,000 
Operating lease right of use – building  68,300   115,800 
Other assets   2,531,400   300,800 

Total assets

 

$

812,500

 

 

$

558,000

 

 $9,617,400  $3,789,300 

 

 

 

 

 

        

Liabilities and Stockholders’ Equity (Deficiency)

 

 

 

 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity        

Current liabilities

 

 

 

 

 

        

Demand loans

 

$

 

$

10,000

 

Convertible debentures

 

128,300

 

128,300

 

Accounts payable

 

4,900

 

33,100

 

 $97,700  $3,700 

Accrued expenses

 

364,700

 

459,900

 

  173,700   151,500 

Deferred revenue

 

 

99,400

 

 

 

106,300

 

Income taxes  287,100    
Operating lease liability – current  50,700   47,500 

Total current liabilities

 

 

597,300

 

 

 

737,600

 

  609,200   202,700 
        
Other liabilities        
Accrued expenses, non-current  172,200   13,000 
Operating lease liability – non-current  17,600   68,300 
Total other liabilities  189,800   81,300 

 

 

 

 

 

        

Commitments and contingencies

 

 

 

 

 

        

 

 

 

 

 

        

Stockholders’ equity (deficiency)

 

 

 

 

 

Series A preferred stock, $1.00 par value

 

 

 

 

 

Authorized - 300,000 shares

 

 

 

 

 

Issued and outstanding - none

 

 

 

Common stock, $0.01 par value

 

 

 

 

 

Authorized - 75,000,000 shares

 

 

 

 

 

Issued and outstanding

 

 

 

 

 

2017 - 58,616,716; 2016 - 58,599,016 shares

 

586,200

 

586,000

 

Stockholders’ equity        
Series A preferred stock, $1.00 par value, authorized – 300,000 shares, Issued and outstanding – none      
Common stock, $0.01 par value, authorized – 75,000,000 shares, Issued and outstanding – 2022 - 9,251,178 shares; 2021 - 6,751,178 shares  92,500   67,500 

Paid-in capital

 

12,440,000

 

12,426,600

 

  16,659,600   13,184,600 

Accumulated deficit

 

 

(12,811,000

)

 

 

(13,192,200

)

  (7,933,700)  (9,746,800)

 

 

215,200

 

 

 

(179,600

)

Total liabilities and stockholders’ equity (deficiency)

 

$

812,500

 

 

$

558,000

 

Total stockholders' equity  8,818,400   3,505,300 
Total liabilities and stockholders’ equity $9,617,400  $3,789,300 



*The accompanying notes are an integral part of these financial statements.






F-3 


Nocopi Technologies, Inc.

Statements of Operations*Comprehensive Income*


 

 

Years ended December 31

 

. Years ended December 31 

 

2017

 

2016

 

 2022  2021 

Revenues

 

 

 

 

 

        

Licenses, royalties and fees

 

$

670,600

 

$

565,000

 

 $3,613,000  $809,900 

Product and other sales

 

 

896,300

 

 

 

818,500

 

  1,014,200   1,142,000 

 

 

1,566,900

 

 

 

1,383,500

 

Total revenues  4,627,200   1,951,900 

 

 

 

 

 

        

Cost of revenues

 

 

 

 

 

        

Licenses, royalties and fees

 

96,500

 

94,800

 

  174,200   168,000 

Product and other sales

 

 

346,600

 

 

 

347,300

 

  553,500   570,100 

 

 

443,100

 

 

 

442,100

 

Total cost of revenues  727,700   738,100 

Gross profit

 

 

1,123,800

 

 

 

941,400

 

  3,899,500   1,213,800 

 

 

 

 

 

        

Operating expenses

 

 

 

 

 

        

Research and development

 

146,300

 

138,800

 

  140,400   181,500 

Sales and marketing

 

253,600

 

236,000

 

  494,500   287,700 

General and administrative

 

 

317,600

 

 

 

294,800

 

  1,219,200   719,400 

 

 

717,500

 

 

 

669,600

 

Total operating expenses  1,854,100   1,188,600 

Net income from operations

 

 

406,300

 

 

 

271,800

 

  2,045,400   25,200 

 

 

 

 

 

        

Other income (expenses)

 

 

 

 

 

        

Interest income

 

500

 

 

  64,200   20,700 

Interest expense, bank charges and accretion of interest

 

 

(25,600

)

 

 

(13,300

)

 

 

(25,100

)

 

 

(13,300

)

Interest expense and bank charges  (2,000)  (2,200)
Total other income (expenses)  62,200   18,500 
Net income before income taxes  2,107,600   43,700 
Income taxes  294,500   (5,700)

Net income

 

$

381,200

 

 

$

258,500

 

 $1,813,100  $49,400 

 

 

 

 

 

        

Net income per common share

 

 

 

 

 

        

Basic

 

$

.01

 

$

.00

 

 $.24  $.01 

Diluted

 

$

.01

 

$

.00

 

 $.24  $.01 

 

 

 

 

 

        

Weighted average common shares outstanding

 

 

 

 

 

        

Basic

 

58,603,441

 

58,599,016

 

  7,584,511   6,743,615 

Diluted

 

58,895,173

 

58,600,257

 

  7,584,511   6,743,615 




*The accompanying notes are an integral part of these financial statements.






F-4 


Nocopi Technologies, Inc.

Statement of Stockholders’ Equity (Deficiency)*Equity*

For the Period January 1, 20162021 through December 31, 20172022


 

 

Common stock

 

 

Paid-in

 

 

Accumulated

 

 

 

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Deficit

 

 

Total

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance - January 1, 2016

 

 

58,599,016

 

 

$

586,000

 

 

$

12,426,600

 

 

$

(13,450,700

)

 

$

(438,100

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

258,500

 

 

 

258,500

 

Balance - December 31, 2016

 

 

58,599,016

 

 

 

586,000

 

 

 

12,426,600

 

 

 

(13,192,200

)

 

 

(179,600

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Debt discount to convertible debentures

 

 

 

 

 

 

 

 

 

 

13,200

 

 

 

 

 

 

 

13,200

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercise of warrants

 

 

17,700

 

 

 

200

 

 

 

200

 

 

 

 

 

 

 

400

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

 

 

 

 

 

 

 

 

 

 

 

 

 

381,200

 

 

 

381,200

 

Balance - December 31, 2017

 

 

58,616,716

 

 

$

586,200

 

 

$

12,440,000

 

 

$

(12,811,000

)

 

$

215,200

 

                     
  Common stock  Paid-in  Accumulated    
  Shares  Amount  Capital  Deficit  Total 
                
Balance – January 1, 2021  6,737,041  $67,400  $13,181,900  $(9,796,200) $3,453,100 
                     
Exercise of warrants  14,137   100   2,700       2,800 
                     
Net income              49,400   49,400 
Balance – December 31, 2021  6,751,178   67,500   13,184,600   (9,746,800)  3,505,300 
                     
Sales of common stock  2,500,000   25,000   3,475,000       3,500,000 
                     
Net income              1,813,100   1,813,100 
Balance – December 31, 2022  9,251,178  $92,500  $16,659,600  $(7,933,700) $8,818,400 




*The accompanying notes are an integral part of these financial statements.







F-5 


Nocopi Technologies, Inc.

Statements of Cash Flows*


 

 

Years ended December 31

 

 Years ended December 31 

 

2017

 

2016

 

 2022  2021 

Operating Activities

 

 

 

 

 

        

Net income

 

$

381,200

 

$

258,500

 

 $1,813,100  $49,400 

Adjustments to reconcile net income to net cash provided by operating activities

 

 

 

 

 

Adjustments to reconcile net income to net cash provided by (used in) operating activities        

Depreciation and amortization

 

7,500

 

7,300

 

  34,100   30,500 

Accretion of interest – convertible debentures

 

 

13,200

 

 

 

500

 

 

 

401,900

 

 

 

266,300

 

 

 

 

 

 

Net income adjusted for non-cash operating activities  1,847,200   79,900 

(Increase) decrease in assets

 

 

 

 

 

        

Accounts receivable

 

(48,700

)

 

9,900

 

  (132,700)  310,000 

Inventory

 

(39,700

)

 

(34,300

)

  (63,700)  (97,900)

Prepaid and other

 

(5,700

)

 

(7,000

)

  56,700   (62,200)

Decrease in liabilities

 

 

 

 

 

Long-term receivables  (2,230,600)  419,000 
Increase (decrease) in liabilities        

Accounts payable and accrued expenses

 

(123,400

)

 

(26,200

)

  227,900   (99,800)

Deferred revenue

 

 

(6,900

)

 

 

(6,100

)

 

 

(224,400

)

 

 

(63,700

)

Net cash provided by operating activities

 

 

177,500

 

 

 

202,600

 

Income taxes  287,100   (36,300)
Total increase in operating capital  263,600   84,500)
Net cash provided by (used in) operating activities  (8,100)  512,700 

 

 

 

 

 

        

Investing Activities

 

 

 

 

 

        

Additions to fixed assets

 

 

(6,600

)

 

 

(1,400

)

  (800)  (31,600)

Net cash used in investing activities

 

 

(6,600

)

 

 

(1,400

)

  (800)  (31,600)

 

 

 

 

 

        

Financing Activities

 

 

 

 

 

        

Repayment of demand loans

 

(10,000

)

 

(13,500

)

Issuance of common stock  3,500,000    

Exercise of warrants

 

 

400

 

 

 

 

     2,800 

Net cash used in financing activities

 

 

(9,600

)

 

 

(13,500

)

Increase in cash

 

161,300

 

187,700

 

Cash

 

 

 

 

 

Net cash provided by financing activities  3,500,000   2,800 
Increase in cash and cash equivalents  3,491,100   483,900 
        
Cash and Cash Equivalents        

Beginning of year

 

 

199,100

 

 

 

11,400

 

  1,846,700   1,362,800 

End of year

 

$

360,400

 

 

$

199,100

 

 $5,337,800  $1,846,700 

 

 

 

 

 

        

Cash paid for interest

 

$

5,800

 

$

12,600

 

        
Cash paid for taxes $  $38,000 
        
Supplemental Disclosure of Non-Cash Investing and Financing Activities        
Accumulated depreciation and amortization $500  $600 
Furniture, fixtures and equipment $(500) $(600)



*The accompanying notes are an integral part of these financial statements.


F-6 

NOCOPI TECHNOLOGIES, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2022 and 2021






NOCOPI TECHNOLOGIES, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2017 and 2016


1.

Organization of the Company


Nocopi Technologies, Inc. (the “Company”) is organized under the laws of the State of Maryland. Its main business activities are the development and distribution of document security products and the licensing of its patented reactive ink technologies for the Entertainment and Toy and the Document and Product Authentication markets in the United States and foreign countries. TheOur Company operates in one principal industry segment.


2.

Significant Accounting Policies


Financial Statement Presentation -Amounts included in the accompanying financial statements have been rounded to the nearest hundred, except for number of shares and per share information.


Estimates - The preparation of the financial statements in conformity with Accounting Principles Generally Accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the dates of financial statements and the reported amounts of revenues and expenses during the reported periods. Actual results could differ from those estimates.


Cash and cash equivalentsconsistsconsist of demand deposits and money-market funds with two major U.S. banks and investment securities consisting of short-term U.S. Treasury Bills with maturities of less than one year held by a major U.S. bank.


Investment securities held to maturity include any security for which the Company has the positive intent and ability to hold until maturity. These securities are carried at amortized cost.

Accounts receivable and credit policies- Accounts receivable are uncollateralized customer obligations due under normal trade terms generally requiring payment within 30 days from the invoice date. Accounts receivable are stated at the amount billed to the customer. Customer account balances with invoices dated over 90 days old are considered delinquent.


The carrying amount of accounts receivable is reduced by an allowance that reflects management'smanagement’s best estimate of the amounts that will not be collected. Management individually reviews all accounts receivable balances that exceed 90 days from invoice date and based on an assessment of current creditworthiness, estimates the portion, if any, of the balance that will not be collected.


Inventoryconsists primarily of ink components and is stated at the lower of cost (determined by the first-in, first-out method) or net realizable value.


Fixed assets are carried at cost less accumulated depreciation and amortization. Furniture, fixtures and equipment are generally depreciated on the straight-line method over their estimated service lives. Leasehold improvements are amortized on a straight-line basis over the shorter of five years or the term of the lease. Major renovations and betterments are capitalized. Maintenance, repairs and minor items are expensed as incurred. Upon disposal, assets and related depreciation are removed from the accounts and the net amount, less proceeds from disposal, is charged or credited to income.


Patent costsare charged to expense as incurred dueincurred.

Revenues – Our Company follows Accounting Standards Update (“ASU”) 214-09, Revenue from Contracts with Customers (“Topic 606”), using the modified retrospective method. We recognize revenue from fixed fee licensees at a point in time when the term begins if the contract provides for patented ink technology only as it exists at the time that it is granted. However, for license agreements that provide for rights to future ink technology, revenue is recognized over the term of the license agreement. Revenue for per-unit license agreement is recognized in the period that the Company receives the related royalty report. Revenue for product sales is recognized upon shipment to the uncertaintycustomer. There are no contract assets or contract liabilities and therefore no unsatisfied performance obligations. The Company does not offer any warranties, however, damaged products can be returned for credit or refund. For disaggregation of their recoverability as a result of the Company’s adverse liquidity situation in prior periods.revenue by customers and geographic region, see Note 10.


F-7 

NOCOPI TECHNOLOGIES, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2022 and 2021

Revenues - In accordance with Financial Accounting Standards Board Accounting Standards Codification (“FASB ASC”) 605, Revenue Recognition, the Company recognizes revenue when (i) persuasive evidence of a customer or distributor arrangement exists or acceptance occurs, (ii) a retailer, distributor or wholesaler receives the goods, (iii) the price is fixed or determinable, and (iv) collectability of the sales revenue is reasonably assured. Subject to these criteria, the Company will generally recognize revenue upon shipment of product. Revenue from license fees and royalties will be recognized as earned over the license term and unearned revenue is credited to the deferred revenue.


Income taxes - Deferred income taxes are provided for all temporary differences and net operating loss and tax credit carryforwards. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized.





F-7



NOCOPI TECHNOLOGIES, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2017 and 2016


Fair value - The carrying amounts reflected in the balance sheets for cash, receivables, accounts payable and accrued expenses approximate fair value due to the short maturities of these instruments. The carrying amount of the demand loans and the convertible debentures approximates fair value since the interest rate associated with the debt approximates the current market interest rates.


Convertible debentures, for which the embedded conversion feature does not qualify for derivative treatment, are evaluated to determine if the effective or actual rate of conversion per the terms of the convertible note agreement is below market value. In these instances, the Company accounts for the value of the beneficial conversion feature as a debt discount, which is then accreted to interest expense over the life of the related debt using the straight-line method, which approximates the effective interest method.


Stock-based payments - the– Our Company accounts for stock-based compensation under the provisions of FASB ASCFinancial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 718, "Compensation - Stock Compensation", which requires the measurement and recognition of compensation expense for all stock-based awards made to employees and directors based on estimated fair values on the grant date. TheOur Company estimates the fair value of stock-based awards on the date of grant using the Black-Scholes model. The value of the portion of the award that is ultimately expected to vest is recognized as expense over the shorter of the vesting period or the requisite service periods using the straight linestraight-line method. TheOur Company accounts for stock-based compensation awards to nonemployeesnon-employees in accordance with FASB ASCASU 2017-07, with ASU No. 2018-07, Compensation – Stock Based Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting (“ASU 2018-07”), which aligns accounting for share-based payments issued to nonemployees to that of employees under the existing guidance of Topic 718, with certain exceptions. This update supersedes previous guidance for equity-based payments to nonemployees under Subtopic 505-50, "Equity-BasedEquity – Equity-Based Payments to Non-Employees (“ASC 505-50”). Under ASC 505-50, the Company determines the fair value of the warrants or stock-based compensation awards granted as either the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measurable.Non-Employees. All issuances of stock options or other equity instruments to non-employees as consideration for goods or services received by the Company are accounted for based on the fair value of the equity instruments issued. Any stock options issued to non-employees are recorded as an expense and additional paid in capital in stockholders’ equity over the applicable service periods. Non-employee equity basedequity-based payments that do not vest immediately upon grant are recorded as an expense over the service period, as if the Company had paid cash for the services. At the end of each financial reporting period, prior to vesting or prior to the completion of the services, the fair value of the equity based payments will be re-measured and the non-cash expense recognized during the period will be adjusted accordingly. Since the fair value of equity based payments granted to non-employees is subject to change in the future, the amount of the future expense will include fair value re-measurements until the equity based payments are fully vested or the service completed.


Earnings per share - The– Our Company follows FASB ASC 260 resulting in the presentation of basic and diluted earnings per share.Basic earnings per common share are based on the weighted average number of shares outstanding during the periods presented. Diluted earnings per share are computed using weighted average number of common shares plus dilutive common share equivalents outstanding during the period. Potential common shares that would have the effect of increasing diluted earnings per share are considered to be anti-dilutive, i.e. the exercise prices of the outstanding stock options were greater than the market price of the common stock.


The table below presents the computation Since our Company did not have any common stock equivalents outstanding as of December 31, 2022 and 2021, basic and diluted weighted average common shares outstanding:earnings per share were the same.

 

 

 

2017

 

 

2016

 

Basic shares outstanding

 

 

58,603,441

 

 

 

58,599,016

 

Incremental shares from assumed conversion of warrants

 

 

291,732

 

 

 

1,241

 

Diluted shares outstanding

 

 

58,895,173

 

 

 

58,600,257

 


Comprehensive income (loss) - The– Our Company follows FASB ASC 220 in reporting comprehensive income. Comprehensive income is a more inclusive financial reporting methodology that includes disclosure of certain financial information that historically has not been recognized in the calculation of net income. Since theour Company has no items of other comprehensive income, comprehensive income is equal to net income.




F-8



NOCOPI TECHNOLOGIES, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2017 and 2016

 


Recoverability of Long-Lived Assets


TheOur Company follows FASB ASC 360-35, “Impairment or Disposal of Long-Lived Assets.” The Statement requires that long-lived assets and certain identifiable intangibles be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may not be recoverable. TheOur Company is not aware of any events or circumstances which indicate the existence of an impairment which would be material to theour Company’s annual financial statements.


Recently Adopted Accounting Pronouncements


As of December 31, 2022, there were no recently adopted accounting standards that had a material effect on our Company’s financial statements.

F-8 

NOCOPI TECHNOLOGIES, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2022 and 2021

Recently Issued Accounting Pronouncements Not Yet Adopted

In July 2015,June 2016, the FASB issued ASU No. 2015-11,2016-13, InventoryFinancial Instruments – Credit Losses (Topic 330)326),Simplifying the Measurement of InventoryCredit Losses on Financial Instruments. The amendments in this Update requireaffect loans, debt securities, trade receivables, and any other financial assets that have the contractual right to receive cash. The ASU requires an entity to measure inventory atrecognize expected credit losses rather than incurred losses for financial assets. For public entities, the lower of cost or net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. Subsequent measurement is unchanged for inventory measured using LIFO or the retail inventory method. The amendments in this Update are effective for fiscal years beginning after December 15, 2016.2019, including interim periods within those fiscal years. ASU No. 2019-10 extends the effective dates for two years for smaller reporting companies and nonpublic companies.

In August 2020, the FASB issued ASU No. 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40), Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. The Company adoptedamendments in this Update affect entities that issue convertible instruments and/or contracts in an entity’s own equity. For convertible instruments, the instruments primarily affected are those issued with beneficial conversion features or cash conversion features because the accounting models for those specific features are removed. However, all entities that issue convertible instruments are affected by the amendments to the disclosure requirements in this Update. For contracts in an entity’s own equity, the contracts primarily affected are freestanding instruments and embedded features that are accounted for as derivatives under the current guidance because of failure to meet the settlement conditions of the derivatives scope exception related to certain requirements of the settlement assessment. The Board simplified the settlement assessment by removing the requirements (1) to consider whether the contract would be settled in registered shares, (2) to consider whether collateral is required to be posted, and (3) to assess shareholder rights. Those amendments also affect the assessment of whether an embedded conversion feature in a convertible instrument qualifies for the derivatives scope exception. Additionally, the amendments in this Update on January 1, 2017 and there is no material impact of this guidance onaffect the financial statements.


In March 2016, the FASB issued ASU No. 2016-09,Compensation – Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting, which simplifies several aspects of the accountingdiluted EPS calculation for share-based payment award transactions, including: (1) income tax consequences; (2) classification of awards as either equity or liabilities, and (3) classification on the statement of cash flows. For public companies, the amendments in this ASU are effective for annual periods beginning after December 15, 2016, and interim periods within those annual periods. The Company adopted the amendments on January 1, 2017 and they had no impact on the financial statements since any excess tax benefits were fully offset by a valuation allowance and not recognized for financial statement purposes.


Recently Issued Accounting Pronouncements Not Yet Adopted


In May 2014 and April 2016, the FASB issued ASU No. 2014-09 and ASU No. 2016-10,Revenue from Contracts with Customers (Topic 606). The core principle of the guidance isinstruments that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This guidance will supersede current revenue recognition guidance which is effective for the Company on January 1, 2018. Under the new standard, the Company may be required to recognize revenue from license fees at the pointsettled in time when the license is granted as opposed to the recognition as earned over the license term which has been our historical practice. The Company, which presently has no significant new licensescash or license renewals pending, has not determined the method to be used in applying the amendments in this standard.


In May 2017, the FASB issued ASU No. 2017-09,Compensation – Stock Compensation (Topic 718), Scope of Modification Accounting. The amendments in this Update provide guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting.shares and for convertible instruments. The amendments in this Update are effective for allpublic business entities that meet the definition of a Securities and Exchange Commission (SEC) filer, excluding entities eligible to be smaller reporting companies as defined by the SEC, for annual periods, andfiscal years beginning after December 15, 2021, including interim periods within those annual periods,fiscal years. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2017.2023, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The amendments in this UpdateBoard specified that an entity should be applied prospectively to an award modified on or afteradopt the adoption date. The Company does not expect the adoption on January 1, 2018guidance as of the amendments in this Updatebeginning of its annual fiscal year. The Board decided to haveallow entities to adopt the guidance through either a material impact on its financial statements.modified retrospective method of transition or a fully retrospective method of transition.


3.Cash and Cash Equivalents

Schedule of Cash and Cash Equivalents        
  Year ended December 31 
  2022  2021 
Cash and cash equivalents        
Cash and money market funds $917,400  $1,846,700 
U.S. Treasury Bills  4,420,400    
Cash and cash equivalents $5,337,800  $1,846,700 

The amortized cost and fair value of securities held to maturity at December 31, 2022 are as follows:

Schedule of amortized cost and fair value of securities held to maturity        
  

Amortized

Cost

  

Fair

Value

 
U.S. Treasury Bills        
Due January 19, 2023 $1,122,600  $1,123,200 
Due April 20, 2023  1,110,300   1,110,300 
Due July 13, 2023  1,100,300   1,098,300 
Due October 5, 2023  1,087,200   1,087,000 
Total $4,420,400  $4,418,800 

F-9 

NOCOPI TECHNOLOGIES, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2022 and 2021

4. Concentration of Credit Risk


Certain financial instruments potentially subject theour Company to concentrations of credit risk. These financial instruments consist primarily of cash, cash equivalents and accounts receivables.receivable. At December 31, 2017, the2022, our Company’s deposits and short-term investments with a financial institution were $110,400$4,838,000 in excess of the FDIC deposit insurance coverage of $250,000.$250,000. There is a concentration of credit risk with respect to accounts receivable due to the number of major customers.




F-9



NOCOPI TECHNOLOGIES, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2017 and 20165.Long-term Receivables

 


4.

Demand Loans


During 2017,As of December 31, 2022, the Company repaidhad long-term receivables of $2,463,100 from three licensees representing the remaining $10,000 principal balancepresent value of an unsecured loanfixed guaranteed royalty payments that will be payable over varying periods of two through five years that commenced in the second half of 2022 and terminate in the second quarter of 2028. The fixed guaranteed royalty payments result from an individual alongamendments to license agreements with approximately $5,800two existing licensees and a license agreement with a new licensee. The receivable represents the present value of accruedthe fixed minimum annual payments due under the license agreements, discounted at the Company's incremental borrowing rate of 4%. 

The three agreements grant licenses for the use of certain patented ink technology as it exists at the time that it is granted which is considered functional intellectual property. Under Topic 606, a performance obligation to transfer a license for functional intellectual property is satisfied at a point in time and the fixed consideration could be recognized upfront when the Company transfers control of the licensee if certain criteria are met. Specifically, the minimum royalty guarantee could be recognized upfront if the following conditions are met:

·The royalty payment is fixed or determinable
·Collection of the royalty payment is considered probable
·The licensee has the ability to benefit from the licensed technology

The Company determined that the above conditions were met upon execution of the agreements and recognized $2,810,580 of royalty revenue net of imputed interest and at December 31, 2017 had no demand loans outstanding. Duringof $132,300 . The Company also recognized $196,500 of commission expense related to the three license agreements, which is reflected in selling expense on the statement of comprehensive income for the year ended December 31, 2016,2022. The commissions are payable over the term of the agreements and are due when payments are received by the Company. As of December 31, 2022, the accrued commission payable balance was $ 194,700.

The current portion of the three new license agreements and one license agreement entered into in prior years, in the amount of $507,400 and $374,500, is included in accounts receivable on the balance sheet as of December 31, 2022 and 2021.

The following table summarizes the future minimum payments due under the three new license agreements as of December 31, 2022:

Schedule of future minimum payments     
Year Ending December 31:    
2024  $642,000 
2025  $570,000 
2026  $570,000 
2027  $557,500 
2028  $520,000 
Total  $2,859,500 

The Company repaid $13,500has evaluated the collectibility of unsecured loans alongthe long-term receivables and believes them to be fully collectible as of December 31, 2022. However, there can be no assurance that the receivables will not be impaired in the future due to changes in the licensees’ financial condition or other factors.

F-10 

NOCOPI TECHNOLOGIES, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2022 and 2021

The long-term receivables are recorded at its present value as of December 31, 2022, and will be amortized over the term of the license agreements using the effective interest method. The unamortized balance of the receivables as of December 31, 2022 is $2,450,800.

The Company has also considered the potential impact of changes in interest rates on the present value of the three new receivables. A hypothetical 1% increase or decrease in the incremental borrowing rate would result in an approximate $21,400 increase or decrease in the present value of the receivables as of December 31, 2022.

6. Line of Credit

In November 2018, our Company negotiated a $150,000 revolving line of credit with approximately $12,600a bank to provide a source of accrued interest. working capital, if required. The loans boreline of credit is secured by all the assets of our Company and bears interest at the bank’s prime rate for a period of one year and its prime rate plus 1.5% thereafter. The line of credit is subject to an annual ratereview and quiet period. There have been no borrowings under the line of 8%.credit since its inception.


5.7.        Stockholders’ Equity

Convertible Debentures


At December 31, 2017,On August 25, 2022, our Company filed Articles of Amendment to its Articles of Incorporation with the Company had convertible debentures totaling $128,300 outstandingState Department of which are due duringAssessments and Taxation of the third quarterState of 2017.Maryland to effect a one-for-ten (1:10) reverse stock split of our Company’s common stock, par value $0.01 per share. The convertible debentures bear interest at 7%August 25, 2022 Articles of Amendment become effective as of 12:01 a.m. Eastern Standard Time on September 2, 2022 (the “Effective Time”). At the optionEffective Time, every ten shares of the lender, the $128,300 principal of the debentures and accrued interest are convertible in whole or part into common stock of our Company that were issued and outstanding immediately prior to the Company at $0.025Effective Time were changed into one issued and outstanding share of common stock of our Company. The reverse stock split did not affect any stockholder’s ownership percentage of our Company’s shares, except to the limited extent that the reverse stock split resulted in any stockholder owning a fractional share. No fractional shares were issued in connection with the reverse stock split. Each stockholder who would otherwise have been entitled to receive a fraction of a share of our Company’s common stock instead received one whole share of common stock. There was no change to the number of authorized shares or the par value per share. Share and per share amounts have been retroactively restated to reflect the one-for-ten reverse stock split on September 2, 2022.


In March 2017,On August 1, 2022 our Company entered into a stock purchase agreement in connection with a private placement for total gross proceeds of $3.5 million. The stock purchase agreement provided for the issuance of an aggregate of 2,500,000 shares of our Company’s common stock to two investors at a purchase price of $1.40 per share, as adjusted for our Company’s one-for-ten (1:10) reverse stock split of our Company’s common stock, par value $0.01 per share. To enable the private placement transaction, our Company’s Board of Directors approved a 1-for-10 (1:10) reverse stock split of its common stock that was effective on September 2, 2022. On September 13, 2022, the extensionsale pursuant to the stock purchase agreement closed. No placement fees or commissions were paid in connection with this transaction.

During the second quarter of three convertible debentures totaling $33,3002021, holders of the remaining 14,137 warrants that had matured in the third quarterbeen outstanding exercised their options to purchase a total of 2016, one of which is held by a Director of the Company. The maturity dates of the convertible debentures are extended for two years and the conversion rate of the debentures and accrued interest into Common Stock of the Company is reduced from $0.05 to $0.025. In accordance with FASB ASC 470, this modification was recorded as a debt discount to the notes payable of approximately $13,300 with an offsetting credit to additional paid-in capital. This modification of the $33,300 principal of the debentures and accrued interest would result in the issuance of 944,953 additional14,137 shares of Common Stock of the Company if the entire $33,300 principal and all accrued interest through maturity were converted into Common Stock of the Company at the new maturity dates.


In the fourth quarter of 2017, the holders of $95,000 of convertible debentures agreed to extend the maturity dates of those convertible debentures for one year with no change in the terms or conditions of the debentures.


The Company also granted warrants to purchase 691,365 shares of theour Company’s common stock at $0.02$0.20 per share to the holders of the debentures.share. The warrants arewere granted in 2014 to two individuals who acquired convertible debentures from the Company in 2014. The warrants were exercisable two years after issuance and expire seven years after issuance. The fair value of the warrants was determined using the Black-Scholes pricing model. The relative fair value of the warrants was recorded as a discount to the notes payable with an offsetting credit to additional paid-in capital since theour Company determined that the warrants were an equity instrument in accordance with FASB ASC 815. The debt discount related to the warrant issuances has beenwas accreted through interest expense over the term of the notes payable. At December 31, 2022, our Company had no warrants outstanding.


F-11 

NOCOPI TECHNOLOGIES, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2022 and 2021

8.       Income Taxes

The fair value

At December 31, 2022, our Company had federal taxable income of approximately $799,100 after utilization of the warrants was determined using the Black-Scholes pricing model. The relative fair valuefederal net operating loss (NOL’s) carryforwards of the warrants was recorded as a discount to the notes payable with an offsetting credit to additional paid-in capital since the Company determinedapproximately $1,174,300 that the warrants were an equity instrument in accordance with FASB ASC 815. The debt discount related to the warrant issuances has been accreted through interest expense over the term of the notes payable. For the years endedavailable at December 31, 2017 and December 31, 2016, $0 and approximately $500, respectively,2021 to offset future taxable income. There was accreted through interest expense.


6.

Stockholders' Equity


In October 2017, a warrant holder exercised warrants to purchase 17,700 shares of common stock of the Company at exercise prices ranging from $0.01 to $0.03. In September 2017, the common stock private placement was extended to December 31, 2018 by the Company’s Board of Directors.


7.

Other Income (Expenses)


Other income (expenses) in the years ended December 31, 2017 and December 31, 2016 includes interest on unsecured loans from two individuals and on convertible debentures held by nine investors. Also included in other income (expenses) is accretion of debt discounts related to the extension of the maturity dates of $33,300 of convertible debentures.




F-10



NOCOPI TECHNOLOGIES, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2017 and 2016


8.

Income Taxes


There is no provision for federal income taxes for the yearsyear ended December 31, 2017 and December 31, 20162021 due to the availability of NOL’s. State income taxes in 2022 resulted from limitations placed on income tax net operating loss carryforwards.deductions by the Commonwealth of Pennsylvania. At December 31, 20172022 and December 31, 2016, the2021, our Company had state NOL’s approximating $4,183,000$1,792,900 and $4,585,000, respectively. The operating losses at December 31, 2017 are available to offset future taxable income;$2,638,800, respectively; however, if not utilized, they expire in varying amounts through the year 2032. The utilization of these NOL’s to reduce future income taxes will depend on the generation of sufficient taxable income prior to their expiration. There were no material temporary differences for the years ended December 31, 20172022 and December 31, 2016. The2021. Our Company has established a 100% valuation allowance of approximately $1,171,000$143,400 and $1,926,000$457,700 at December 31, 20172022 and December 31, 2016,2021, respectively, for the deferred tax assets due to the uncertainty of their realization.


On December 22, 2017, The Tax Cutscomponents for federal and Jobs Act (the “Act”) was signed into law. The Act decreases the U.S. corporate federalstate income tax rate from a maximum of 35% to a flat 21% effective January 1, 2018. The impact of the re-measurement on the Company’s net tax asset, as of December 31, 2017, was a decrease of approximately $586,000 in deferred tax assets with a corresponding decrease in the Company’s valuation allowance.expense are:


State Income Tax Expense        
  Year ended December 31 
  2022  2021 
Current federal taxes $167,800  $ 
Current state taxes  126,700   (5,700)
  $294,500  $(5,700)

The reconciliation of the statutory federal rate to the Company'sour Company’s effective tax rate follows:


 

 

2017

 

 

2016

 

 

 

Amount

 

 

%

 

 

Amount

 

 

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income tax benefit at U.S. federal income tax rate

 

(1,422,300

)

 

 

(34

)

 

(1,558,800

)

 

 

(34

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

State tax net of federal tax effect

 

 

(334,600

)

 

 

(8

)

 

 

(366,800

)

 

 

(8

)

Tax rate change

 

 

585,600

 

 

 

14

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Change in valuation allowance

 

 

1,171,300

 

 

 

28

 

 

 

1,925,600

 

 

 

42

 

 

 

$

 

 

 

 

 

$

 

 

 

 

Reconciliation of the Statutory Federal Rate                
  2022  2021 
  Amount  %  Amount  % 
             
Income tax at U.S. federal income tax rate $442,600   21  $9,700   21 
                 
State tax net of federal tax effect  166,300   8   (2,600)  (5)
                 
Other        (13,800)  (30)
                 
Increase in (utilization of ) operating losses  (314,400)  (15)  1,000   2 
  $294,500   14  $(5,700)  (12)


The components of deferred tax assets and liabilities as of December 31, 2022 and 2021 are as follows:

Deferred Tax Assets and Liabilities        
  2022  2021 
       
Deferred tax asset for NOL carryforwards $143,400  $457,700 
         
Deferred tax liability - other        
Valuation allowance  (143,400)  (457,700)
Deferred tax liability  $  $ 

Our Company has adopted the provisions offollows FASB ASC 740-10-50-15, “Unrecognized Tax Benefit Related Disclosures.” There were no740.10, which provides guidance for the recognition and measurement of certain tax positions in an enterprise’s financial statements. Recognition involves a determination of whether it is more likely than not that a tax position will be sustained upon examination with the presumption that the tax position will be examined by the appropriate taxing authority having full knowledge of all relevant information.

Our Company’s policy is to record interest and penalties associated with unrecognized tax benefits as additional income taxes in the statement of the datecomprehensive income. As of adoption and January 1, 2022, our Company had no unrecognized tax benefits at December 31, 2017. There was and no change in charge during 2022, and accordingly, our Company did not recognize any interest or penalties during 2022 related to unrecognized tax benefits during the year ended December 31, 2017 and there was benefits. There is no accrual for uncertain tax positions as of December 31, 2017.2022.


There were no interest and penalties recognized in the statement of operations and in the balance sheet. Tax years from 20132020 through 20172022 remain subject to examination by U.S. federal and state tax jurisdictions.


9.

Related Party Transactions


In each of the years ended December 31, 2017 and December 31, 2016, Michael A. Feinstein, M.D., the Company’s Chairman of the Board and Chief Executive Officer, deferred $85,000 of salary owed to him under an employment agreement with the Company. At December 31, 2017 and December 31, 2016, Dr. Feinstein was owed $200,000 and $301,200, respectively, of salary that was deferred by him in response to the adverse liquidity experienced by the Company beginning in 2012. There are no formal terms or arrangements for repayment of the deferred salary. During the years ended December 31, 2017 and 2016 the Company made payments of $186,200 and $74,200, respectively, to Dr. Feinstein, representing a portion of amounts owed to him. During the first three months of 2018, the Company made additional deferred salary payments of $70,700 to Dr. Feinstein. There is no interest payable on the deferred salary.


10.

F-12 

NOCOPI TECHNOLOGIES, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2022 and 2021

9.       Commitments and Contingencies


TheOur Company conducts its operations in leased facilities under a non-cancelable operating lease expiring in 2019.2024.


FutureDue to the adoption of the new lease standard under the optional transition method which allows the entity to apply the new lease standard at the adoption date, our Company has capitalized the present value of the minimum lease payments under non-cancelable operating leases with initial or remaining termscommencing January 1, 2019, using an estimated incremental borrowing rate of one year or more at December 31, 2017 are: $48,600 – 2018 and $16,300 – 2019.



F-11



NOCOPI TECHNOLOGIES, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2017 and 20166%. The minimum lease payments do not include common area annual expenses which are considered to be non-lease components.

 


As of January 1, 2019 the operating lease right-of-use asset and operating lease liability amounted to $241,100 with no cumulative-effect adjustment to the opening balance of accumulated deficit.

There are no other material operating leases. Our Company has elected not to recognize right-of-use assets and lease liabilities arising from short-term leases.

Total rentallease expense under operating leases was $45,100$53,300 in each of the years ended December 31, 20172022 and December 31, 2016.2021.


TheMaturities of lease liabilities are as follows:

Maturities of Lease Liabilities    
  Operating Leases 
Year ending December 31    
2023 $56,200 
2024  18,900 
Total lease payments  75,100 
Less imputed interest  (6,800)
Total $68,300 

Our Company has an employment agreement, expiring in May 2019,2024, with Michael A. Feinstein, M.D., its Chairman of the Board and Chief Executive Officer. The employment agreement contains one-year renewal provisions that became effective after the original term. Dr. Feinstein receives base compensation of $85,000$120,000 per year effective January 1, 2020 plus a performance bonus determined by theour Company’s Board of Directors. TheOur Company has an employment agreement, expiring in March 2019,2024, with Terry W. Stovold, its Chief Operating Officer, whereby Mr. Stovold receives a salary set by theour Company’s Board of Directors, currently set at $75,000,$75,000, along with a commission of seven percent on sales generated by his efforts. The employment agreement contains one-year renewal provisions that became effective after the original term. Our Company has an employment agreement, expiring in September 2024, with Matthew C. Winger, its Executive Vice President of Corporate Development, whereby Mr. Winger receives a salary set by our Company’s Board of Directors, currently set at $125,000 per year effective October 1, 2022 plus a performance bonus determined by our Company’s Board of Directors. The employment agreement contains two-year renewal provisions that become effective after the original term. Future minimum compensation payments under these employment agreements are: $160,000$320,000 to be paid in 20182023 and $54,200$162,500 to be paid in 2019.2024.


From time to time, theour Company may be subject to legal proceedings and claims that arise in the ordinary course of its business.


11.

10.       Stock Options, Warrants and 401(k) Savings Plan


TheOur Company follows FASB ASC 718,Share Based Payment,which requires that the cost resulting from all share-based payment transactions be recognized in the Company’s financial statements. FASB ASC 718 requires all share-based payments to employees, including grants of employee stock options, to be recognized in the statement of operationscomprehensive income based on their fair values.


At December 31, 2017, the2022, our Company did not have an active stock option plan. TheOur Company uses the Black-Scholes option pricing model to calculate the grant-date fair value of an award. There was no compensation expense recognized during the years ended December 31, 20172022 and December 31, 20162021 and there was no unrecognized portion of expense at December 31, 2017.2022.


F-13 

NOCOPI TECHNOLOGIES, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2022 and 2021

At December 31, 2017, the2022 and December 31, 2021, our Company had 691,365no outstanding warrants to purchase common stock of the Company outstanding at an exercise price of $0.02 and expiring at various dates through July 2021. The warrants are held by ten investors who acquired convertible debentures from the Company in 2013 and 2014.


our Company. A summary of outstanding warrantswarrant activity follows:


 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

Exercise

 

 

Average

 

 

 

Number of

 

 

Price Range

 

 

Exercise

 

 

 

Shares

 

 

Per Share

 

 

Price

 

Outstanding at December 31, 2015

 

756,365

 

 

$0.01 to $0.07

 

 

$0.022

 

Warrants expired

 

  35,000

 

 

0.045 and 0.06

 

 

  0.051

 

Outstanding at December 31, 2016

 

721,365

 

 

0.01 to 0.07

 

 

  0.021

 

Warrants exercised

 

  17,700

 

 

0.01 to 0.03

 

 

  0.021

 

Warrants expired

 

  12,300

 

 

0.06 and 0.07

 

 

  0.063

 

Outstanding at December 31, 2017

 

691,365

 

 

$0.02

 

 

$0.02

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average remaining contractual life (years)

 

2.83

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

 

Exercise

 

 

 

Average

 

 

 

 

 

 

 

Price Range

 

 

 

Exercise

 

 

 

Shares

 

 

 

Per Share

 

 

 

Price

 

Exercisable warrants at year end:

 

 

 

 

 

 

 

 

 

 

 

 

2017

 

691,365

 

 

$0.02

 

 

$0.02

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average remaining contractual life (years)

 

2.83

 

 

 

 

 

 

 

 

 




F-12



NOCOPI TECHNOLOGIES, INC.

NOTES TO FINANCIAL STATEMENTS

December 31, 2017 and 2016

Outstanding Warrants            
        Weighted 
     Exercise  Average 
  Number of  Price Range  Exercise 
  Shares  Per Share  Price 
Outstanding at December 31, 2020  14,137  $0.20  $0.20 
Warrants exercised  14,137   0.20   0.20 
Outstanding at December 31, 2021         
          
Outstanding at December 31, 2022         

 


At December 31, 2017, the Company has reserved 7,524,942 shares of common stock for possible future issuance upon exercise of 691,365 warrants and for the conversion of approximately $128,300 of convertible debentures and accrued interest into 6,833,577 shares of common stock.


TheOur Company sponsors a 401(k) savings plan, covering substantially all employees, providing for employee and employer contributions. Employer contributions are made at the discretion of theour Company. There were no contributions charged to expense during 20172022 or 2016.2021.


12.

11.        Major Customer and Geographic Information


TheOur Company’s revenues, expressed as a percentage of total revenues, from non-affiliated customers that equaled 10% or more of theour Company’s total revenues were:


Revenues from Non-affiliated Customers      

 

Year ended December 31

 

 Year ended December 31 

 

2017

 

 

2016

 

 2022  2021 

Customer A

 

 

43

%

 

38

%

 66%  27% 

Customer B

 

26

%

 

25

%

 19%  48% 

Customer C

 

9

%

 

14

%


TheOur Company’s non-affiliate customers whose individual balances amounted to more than 10% of theour Company’s net accounts receivable, expressed as a percentage of net accounts receivable, were:


Non-affiliated Customers with Accounts Receivable More Than 10%      

 

December 31

 

 December 31 

 

2017

 

 

2016

 

 2022  2021 

Customer A

 

 

14

%

 

26

%

 84%  74% 

Customer B

 

47

%

 

47

%

   6%  21% 

Customer C

 

15

%

 

5

%


TheOur Company performs ongoing credit evaluations of its customers and generally does not require collateral. TheOur Company also maintains allowances for potential credit losses. The loss of a major customer could have a material adverse effect on theour Company’s business operations and financial condition.


The Our Company’s revenues by geographic region are as follows:


Revenue by Geographic Region      

 

Year ended December 31

 

 Year ended December 31 

 

2017

 

2016

 

 2022  2021 

North America

 

$

713,200

 

$

608,000

 

 $3,331,600  $812,800 

South America

 

1,500

 

 

 1,600  4,100 

Europe

 

300

 

 

 200   

Asia

 

822,300

 

745,900

 

 968,000  1,041,300 

Australia

 

 

29,600

 

 

 

29,600

 

  325,800   93,700 

 

$

1,566,900

 

 

$

1,383,500

 

 $4,627,200  $1,951,900 









 




F-13 


Exhibit Index


The following Exhibits are filed as part of this Annual Report on Form 10-K:


Exhibit

Number

Description

Location

3.1 

3.1

Amended and Restated Articles of Incorporation

Incorporated by reference to Exhibit 3.1 of the Registrant’s Quarterly Report onCompany’s Form 10-Q for the Three Months Ended September 30, 2008 filed on November 14, 2008

3.2

Amended and Restated BylawsArticles of Amendment - Filed August 25, 2022

Incorporated by reference to Exhibit 3.2 of the Registrant’s QuarterlyCompany’s Report on Form 10-Q for the Three Months Ended September 30, 20088-K filed on November 14, 2008

08/25/22

4.1

3.2

Second Amended and Restated Bylaws, Dated January 28, 2022

Incorporated by reference to the Company’s Form 8-K filed on February 2, 2022
3.3Articles Supplementary relating to Nocopi Technologies, Inc.’s election to be subject to Sections 3-803, 3-804(a), 3-804(b) and 3-804(c) of the Maryland General Corporation LawIncorporated by reference to the Company’s Form 8-K filed on October 29, 2021
4.1Form of Certificate of Common Stock

Incorporated by reference to Exhibit 4.1 of the Registrant’sCompany’s Annual Report on Form 10-KSB for the Year Ended December 31, 2005 filed on April 7, 2006

10.1†

4.2

Registration Rights Agreement – Dated August 1, 2022

 

Nocopi Technologies, Inc. 1998 Stock Incentive Plan

Incorporated by reference to Registrant’s Annual Reportthe Company’s Form 8-K filed on Form 10-KSB for the Year Ended December 31, 1998

08/05/22

10.2†

4.3

Securities registered under Section 12 of the Exchange Act

Filed herewith
10.1†Amended Summary Plan Description for Nocopi Technologies, Inc. 401(k) Profit Sharing Plan

Incorporated by reference to Exhibit 10.15 of the Registrant’sCompany’s Annual Report on Form 10-KSB for the Year Ended December 31, 1998 filed on April 15, 1999

10.3

10.2

Director Indemnification Agreement

Incorporated by reference to Exhibit 10.19 of the Registrant’sCompany’s Quarterly Report on Form 10-QSB for the Three Months Ended September 30, 1999 filed on November 15, 1999

10.4

10.3

Officer Indemnification Agreement

Incorporated by reference to Exhibit 10.20 of the Registrant’sCompany’s Quarterly Report on Form 10-QSB for the Three Months Ended September 30, 1999 filed on November 15, 1999

10.5

10.4†

Stock Purchase Agreement with Westvaco Brand Security, Inc.

Incorporated by reference to Exhibit 10.17 of the Registrant’s Annual Report on Form 10-KSB for the Year Ended December 31, 2000 filed on April 17, 2001

10.6

Registration Rights Agreement with Westvaco Brand Security, Inc.

Incorporated by reference to Exhibit 10.18 of the Registrant’s Annual Report on Form 10-KSB for the Year Ended December 31, 2000 filed on April 17, 2001

10.7

Subscription Agreement with Entrevest I Associates

Incorporated by reference to Exhibit 10.18 of the Registrant’s Annual Report on Form 10-KSB for the Year Ended December 31, 2002 filed on April 14, 2003

10.8

Settlement Agreement with Euro-Nocopi, S.A.

Incorporated by reference to Exhibit 10.17 of the Registrant’s Annual Report on Form 10-KSB for the Year Ended December 31, 2003 filed on April 14, 2004










10.9

Agreement of Terms with Entrevest I Associates

Incorporated by reference Exhibit 10.1 of the  Registrant’s Current Report on Form 8-K filed on September 16, 2004

10.10

Conversion Agreement

Incorporated by reference to Exhibit 10.2 of the Registrant’s Quarterly Report on Form 10-QSB for the Three Months Ended September 30, 2004 filed on November 15, 2004

10.11†

Employment Agreement with Michael A. Feinstein, M.D.

Incorporated by reference to Exhibit 10.17 of the Registrant’sCompany’s Quarterly Report on Form 10-Q for the Three Months Ended June 30, 2008 filed on August 14, 2008

10.12†

10.5†

Employment Agreement Amendment - Michael A. Feinstein, M.D.

Incorporated by reference to the Company’s Form 8-K filed on December 17, 2019
10.6†Employee Agreement dated September 29, 2022 - Matthew C. WingerIncorporated by reference to the Company’s Quarterly Report on Form 10-Q filed on 09/30/22
10.7†Amended Summary Plan Description for Nocopi Technologies, Inc. 401(k) Profit Sharing Plan

Incorporated by reference to Exhibit 10.19 of the Registrant’sCompany’s Annual Report on Form 10-K for the Year Ended December 31, 2009 filed on March 31, 2010

10.13†

10.8†

Employment Agreement with Terry W. Stovold

Incorporated by reference to Exhibit 10.19 of the Registrant’sCompany’s Annual Report on Form 10-K for the Year Ended December 31, 2011 filed on March 30, 2012

10.14

10.9

Conversion Agreement

Incorporated by reference to Exhibit 10.20 of the Registrant’s Annual Report on Form 10-K for the Year Ended December 31, 2011 filed on March 30, 2012

10.15

Form of Convertible Debenture Purchase Agreement and Exhibits

Incorporated by reference to Exhibit 10.19 of the Registrant’sCompany’s Annual Report on Form 10-K for the Year Ended December 31, 2014 filed on September 11, 2015

10.16

10.10
Form of Letter Agreement re: Convertible Debenture Purchase Agreement ElectionIncorporated by reference to the Company’s Quarterly Report on Form 10-Q filed on November 13, 2019 

 

10.11

Lease Agreement dated December 12, 2013 relating to premises at 480 Shoemaker Road, King of Prussia, PA 19406

Incorporated by reference to Exhibit 10.20 of the Registrant’sCompany’s Annual Report on Form 10-K for the Year Ended December 31, 2014 filed on September 11, 2015

14.1

10.12

Code of EthicsLease Extension Agreement dated September 28, 2018

Incorporated by reference to Exhibit 14.1the Company’s Annual Report on Form 10-K filed on March 29, 2019 

10.13Business Loan Agreement, Promissory Note and Commercial Security Agreement dated November 28, 2018 between the Company and Santander BankIncorporated by reference to the Company’s Annual Report on Form 10-K filed on March 29, 2019
10.14Form of Letter Agreement re: Convertible Debenture Purchase Agreement ElectionIncorporated by reference to the Registrant’sCompany’s Quarterly Report on Form 10-Q filed on November 13, 2019
10.15Stock Purchase Agreement - Dated August 1, 2022Incorporated by reference to the Company’s Annual Report on Form 10-K filed on 08/05/22
14.1Code of EthicsIncorporated by reference to the Company’s Annual Report on Form 10-KSB for the Year Ended December 31, 2004 filed on March 31, 2005

31.1

21.1

Subsidiaries of the Registrant

Filed herewith
31.1Certification of Chief Executive Officer required by Rule 13a-14(a)

Filed herewith

31.2

Certification of Chief Financial Officer required by Rule 13a-14(a)

Filed herewith

32.1

Certifications of Chief Executive Officer and Chief Financial Officer Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Furnished herewith

101.INS

99.1

Second Amendment to Nomination and Standstill Agreement dated September 30, 2022, between the Company and MSL 18 HOLDINGS LLC, Michael S. Liebowitz and Matthew C. Winger

Incorporated by reference to the Company’s Quarterly Report on Form 10-Q filed on 09/30/22
99.2First Amendment to Nomination and Standstill Agreement dated May 23, 2022, between the Company and MSL 18 HOLDINGS LLC, Michael S. Liebowitz and Matthew C. Winger Incorporated by reference to the Company’s Quarterly Report on Form 10-Q filed on 05/24/22
99.3Nomination and Standstill Agreement dated March 29, 2022, between the Company and MSL 18 HOLDINGS LLC, Michael S. Liebowitz and Matthew C. Winger Incorporated by reference to the Company’s Quarterly Report on Form 10-Q filed on 03/29/22
99.4Standstill Agreement dated May 23, 2022, between the Company and Howard Timothy Eriksen, Cedar Creek Partners, LLC and Eriksen Capital Management LLC.Incorporated by reference to the Company’s Current Report on Form 8-K filed on 05/24/22
101.INSInline XBRL Instance Document

(the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)

101.SCH

Inline XBRL Taxonomy Extension Schema Document

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase

Document

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document

104Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

———————

† Compensation plans and arrangements for executives and others.